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1. RATIONALE 
 
A diet rich in vegetables and fruit has been associated with a reduced risk of various common 
cancers, particularly of the respiratory and digestive tracts [1]. With specific focus to a network of 
Italian case-control studies conducted since the early 1990’s (Figures 1 and 2), vegetable intake was 
inversely related to the risk of several common epithelial cancers: the odds ratios (OR) for digestive 
tract neoplasms ranged between 0.3 and 0.8 for the highest compared with the lowest levels of 
vegetable intake. Less consistent inverse relations were observed for some hormone-related 
neoplasms, such as breast and ovary. High fruit intake was associated to reduced ORs of cancers of 
the upper digestive tract, stomach, colorectum, and Non-Hodgkin’s lymphomas. No material effect, 
however, was observed for fruit intake on neoplasms of the breast, the female genital tract or the 
prostate [2]. For digestive tract cancers, population-attributable risks for low intake of vegetables 
and fruit ranged between 15 and 40% [3].  
Further investigations have tried to understand whether such a favorable effect may be attributed to 
specific vitamins, micronutrients or bioactive compounds contained in plant foods. Flavonoids - a 
large group of phytochemicals with a similar structure, naturally occurring in vegetables, fruit, and 
beverages of plant origin - have shown antioxidant, antimutagenic, and antiproliferative properties 
in vitro [4, 5], and have thus been suggested to have a potential protective effect on common 
cancers [6-9].  
The availability of detailed and reliable food composition tables for flavonoids published by the US 
Department of Agriculture on their 6 major classes (flavanols, flavanones, flavonols, flavones, 
anthocyanidins and isoflavones) [10, 11], and, more recently, on a class of polymers of flavanols 
called proanthocyanidins [12] has allowed epidemiological studies to further investigate the role of 
flavonoids in cancer etiology from the early 2000’s. Intake of various flavonoids has been inversely 
related to the risk of cancers of the upper aerodigestive tract [13], digestive tract [14, 15], breast 
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[16, 17], and urogenital tract [18, 19]. No epidemiological study has investigated systematically the 
relation of dietary proanthocyanidins by their degree of polymerization with cancer risk. 
Given the high correlation between dietary factors, it is difficult to disentangle the effect of various 
factors and detect which specific component or group of components is the responsible for a 
protective role against cancer. Moreover, since several antioxidants influence cancer risk and may 
act synergistically against oxidative stress to prevent carcinogenesis, examining overall antioxidant 
exposure rather than individual antioxidants has recently been suggested [20]. An inverse 
association between total antioxidant capacity (TAC) and rectal cancer risk has been reported from 
a large US cohort study [20].  
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2. OBJECTIVES 
 
I first used multiple logistic regression to study the relation between flavonoids and cancer risk. In 
particular, I investigated flavonoids in relation to the risk of various neoplasms in a series of case-
control studies conducted in Italy [21] and a study conducted in Greece [22], which included 
cancers of the oral cavity and pharynx, esophagus, larynx, stomach, colorectum, liver, pancreas, 
breast, ovary, prostate, and kidney. 
I then developed a standardized method to compute the three measures of TAC (TEAC, TRAP and 
FRAP) in order to take into account the total amount of antioxidants deriving by diet in the analysis 
for flavonoids and to investigate TAC in relation to the risk of various cancers. 
I focused my research on dealing with the high collinearity problems the I encountered in the 
analysis on colorectal and oral and pharyngeal cancers. In particular, the following issues have been 
addressed by using different statistical techniques of multivariate analysis: 
1 collinearity within classes of flavonoids: which class of flavonoids is associated with cancer risk 
adjusting for other classes of flavonoids?  
2 collinearity between flavonoids and some major food sources of flavonoids associated to cancer 
risk, especially wine: how to estimate the association between flavonoids and cancer risk excluding 
the confounding of detrimental effect of wine consumption? 
3 collinearity between flavonoids and other biocative compounds contained in plant foods 
(vitamins, carotenoids, etc.): how to estimate the association between flavonoids and cancer risk 
excluding the confounding effect of compounds deriving by food sources similar to those of 
flavonoids? 
At last, I took into account the bias due to the possible over-reporting of cases in case-control 
studies by proposing a new statistical approach, based on the residual method.  
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3. MATERIAL AND METHODS 
 
3.1 Description of data 
I used data from a series of case-control studies conducted in various regions of Italy since the early 
1990s [21]. These studies included a total of 9622 cancer cases and 16 050 controls. In particular, 
the study on oral cavity and pharynx cancers was conducted between 1992 and 2005 in Northern 
and Central Italy and included 805 cases and 2081 controls; the study on esophageal cancer was 
conducted between 1992 and 1997 in Northern and Central Italy and included 304 cases and 743 
controls; the study on laryngeal cancer was conducted between 1992 and 2000 in Northern Italy and 
included 460 cases and 1088 controls; the study on stomach cancer was conducted between 1997 
and 2007 in the Greater Milan area and included 230 cases and 547 controls; the study on colorectal 
cancer was conducted between 1992 and 1996 in six Italian areas  and included 1953 cases and 
4154 controls; the study on pancreatic cancer was conducted between 1991 and 2008 in northern 
Italy, and included 326 cases and 652 frequency matched control; the study on breast cancer was 
conducted between 1991 and 1994 in six Italian areas  and included 2569 cases and 2588 controls; 
the study on ovarian cancer was conducted between 1992 and 1999 in Northern and Central Italy  
and included 1031 cases and 2411 controls; the study on prostatic cancer was conducted between 
1991 and 2002 in four Italian areas and included 1294 cases and 1451 controls; the study on renal 
cancer was conducted between 1992 and 2004 in four Italian areas and included 7670 cases and 
1534 controls.  
I also analyzed data from a case-control study on liver cancer conducted in Greece between 1995 
and 1998 in three teaching hospitals of Athens; the study included 230 cases and 547 controls.  
In Italian studies, cases were individuals admitted to hospitals with incident, histologically 
confirmed cancer, and controls were patients with no history of cancer admitted to the same 
hospitals for acute, nonneoplastic conditions. Centrally trained interviewers administered a standard 
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questionnaire to cases and controls during their hospital stay. The questionnaire included personal 
and socio-demographic characteristics, anthropometric measures, and lifestyle habits, including 
tobacco smoking and alcohol consumption. A reproducible [23] and valid [24] food frequency 
questionnaire (FFQ) was used to assess the patients’ usual diet in the 2 years preceding diagnosis 
(for cases) or hospital admission (for controls). The FFQ included the average weekly consumption 
of 78 food items or food groups and beverages. Intakes lower than once a week, but at least once 
per month were coded as 0.5 per week.  
In the Greek study, cases were incident and histologically confirmed cancers and controls were 
patients hospitalized with non-cancer disorders usually requiring some minor operations. All 
subjects were interviewed in the hospital using a standardized semiquantitative FFQ including 100 
different foods or beverages, which has been subsequently validated [25, 26]. Data concerning 
demographic, socio-economic, and medical variables were recorded, and detailed histories smoking 
habits and 80 alcohol consumption were taken. 
 
3.2 Dietary factors estimates 
I developed a standardized method based on food composition tables in terms of flavonoids and 
proanthocyanidins in order to translate the frequency of consumption of each food item of the FFQ 
into average daily intakes of flavonoids and proanthocyanidins, taking into account the portion size 
of each item food. For the six major classes of flavonoids, i.e., flavanols, flavanones, flavonols, 
anthocyanidins, flavones, and isoflavones, I used food composition data published by the US 
Department of Agriculture (USDA) [10, 11], further integrated with other sources when needed 
[27-29]. Major flavonoids included in the six classes were epicathechin and catechin for flavanols, 
hesperetin and naringerin for flavanones, quercetin for flavonols, cyanidin and malvidin for 
anthocyanidins, apigenin and luteolin for flavones, and daidzein and genistein for isoflavones. In 
our control population, flavanols came mainly from tea, apples, pears and wine; flavanones from 
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oranges and other citrus fruits; flavonols from apples, pears and various common vegetables; 
anthocyanidins from wine, strawberries, cherries and onions; flavones from cooked vegetables and 
tea; and isoflavones from soya and bean soups (Table 1). 
For proanthocyanidins, data from the USDA became available more recently [12]. Since analytical 
technology did not allow quantification of these compounds according to their type linkage (e.g., 
procyanidins, prodelphinidins, etc.), but only according to their degree of polymerization, the 
USDA food composition tables were in terms of six classes of proanthocyanidins, i.e., monomers, 
dimers, trimers, 4-6 mers, 7-10 mers, > 10 mers [12]. Given the high correlation between some 
classes of proanthocyanidins, I further combined monomers and dimers, as well as polymers with 
three or more mers, and also studied total proanthocyanidins. In our data, the major sources of 
combined monomers and dimers of proanthocyanidins were wine, apples or pears, peaches, apricots 
or prunes, whereas major sources of proanthocyanidins with three or more mers were apples or 
pears, wine, vegetables or bean soup (Table 1). Other main sources are chocolate, pulses and grape. 
Nutrients and energy intakes were computed using an Italian food composition database, integrated 
with others published data [30, 31]. Greek food composition tables for the liver cancer study were 
used [32]. 
Similarly, I quantified the TAC of the diet of each subject by computing TEAC (Trolox Equivalent 
Antioxidant Capacity), TRAP (Total Radical-trapping Antioxidant Parameter), and FRAP (Ferric 
Reducing-Antioxidant Power) through Italian food tables in terms of these three assays recently 
published from the National Institute for Food and Nutrition [33]. Concerning TEAC, the assay 
measures the ability of antioxidant molecules to quench the long-lived ABTS
.+
, compared with that 
of Trolox, a water-soluble vitamin E analog. TEAC is expressed in mmol of Trolox per kg (solid 
foods and oils) or per L (beverages) of sample. For TRAP, the assay gives a measure of the 
protection provided by antioxidants on the fluorescence decay of R-phycoerythrin (lag-phase) 
during a controlled peroxidation reaction. TRAP values were calculated from the length of the lag-
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phase due to the sample compared with that of Trolox and expressed as mmol of Trolox per kg 
(solid foods) or per L (beverages) of sample. For FRAP, the assay measures the reduction of the 
Fe3
+
-TPTZ complex to the ferrous form at low pH. FRAP values were obtained by comparing the 
absorption change in the test mixture with those obtained from increasing concentrations of Fe3
+
 
and expressed as mmol of Fe2
+
 equivalents per kg (solid food) or per L (beverages) of sample. The 
principal food sources of TAC included wine, citrus fruits, apples and pears, and bread. 
 
3.3 Statistical analysis 
3.3.1 Logistic regression 
I derived the ORs and the corresponding 95% confidence intervals (CIs), by multiple logistic 
regression models [34] including terms for study centre, sex, age, education, energy intake, as well 
as other major recognized confounding factors for each cancer of interest. These included alcohol 
consumption, tobacco smoking and body mass index (BMI) for upper aerodigestive tract 
neoplasms; calendar year of interview, tobacco smoking, and BMI for stomach cancer; alcohol 
consumption, BMI, occupational physical activity, family history of colorectal cancer for colorectal 
cancer; year of interview, alcohol consumption, tobacco smoking, history of diabetes for pancreatic 
cancer; alcohol consumption and parity for breast cancer; alcohol consumption, parity, oral 
contraceptives and family history of ovarian and/or breast cancer for ovarian cancer; BMI and 
family history of prostate cancer for prostate cancer; alcohol consumption, tobacco smoking, BMI, 
occupational physical activity, and family history of kidney cancer for renal cell carcinomas. 
According to the study design, I used unconditional or conditional logistic models, matched for 
study centre, sex, and age. Terms for age were generally entered in the models as quinquennia 
(categorically), education as three categories (<7, 7-11,  12 years, categorically), alcohol 
consumption as quartiles (categorically) and number of drinks (continuously), tobacco smoking as 
four categories (ex smokers, <25,  25 cigarettes per day, categorically), BMI as quintiles 
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(categorically), physical activity as three categories (low, medium, and high, categorically), family 
history of cancer as dummy (Yes/No).  
Adjustment for energy intake was performed entering the term in the model (with or without energy 
from alcohol intake) and using the residual method [35]. Because both analyses yielded similar 
results, only the former estimates generally were presented. 
In the Greek liver cancer study, odds ratios and 95% CI 108 were estimated by modelling the data 
through logistic regression, including terms for age (quinquennia, categorically), years of education 
(<12, ≥12 years), tobacco smoking (never smokers, ever smokers of < 25, ≥ 25 cigarettes per day), 
and total energy intake (quintiles, categorically). 
Flavonoids or the variables of interest were entered in the models as quintiles or tertiles computed 
on the distribution of controls. ORs per an increment of intake equal to one standard deviation 
based on control distribution were also computed. Tests for trend for quintiles were based on the 
likelihood ratio test between the models with and without a linear term for quintiles. 
I separated the relation with flavonoids and proanthocyanidins from their major sources by mutual 
adjustment. Similarly, I computed ORs for flavonoids and proanthocyanidins mutually adjusted for 
other classes of flavonoids and proanthocyanidins. I also examined additional models including 
terms for intakes of vitamin C, vitamin E, potassium and folate. In case of a high collinearity, I 
compared the standardized regression coefficients.  
Moreover, I estimated the ORs for flavonoid and proanthocyanidin intake in the models further 
adjusted for TAC intake in order to investigate whether antioxidant capacity could explain the effect 
of some classes of flavonoids and proanthocyanidins on colorectal cancer risk or the associations 
with flavonoids and proanthocyanidins were independent of TAC.  
3.3.2 Factor analysis 
I used factor analysis (FA) in order to describe the “Fconstruct of flavonoids “ in terms of a minor 
underlying quantities (called factors) [36]. If flavonoids within a particular group are highly 
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correlated among themselves and have relatively small correlations with variables in a different 
group, then each group of variables may represent a single underlying factor. 
Among the assumption of exploratory FA there are large sample size, continuous distributions, and 
linear relationship among variables, typical for Pearson correlation. 
Let X be the observable random vector with p components, mean μ and covariance matrix Σ. The 
factor model postulates that X is linearly dependent upon a few unobservable random variables F1, 
F2, …, Fm, called common factors, and p additional sources of variations ε1, ε2, …, εp, called errors. 
In particular, the FA model is: 
pmpmpppp
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mm
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or, in matrix notation: 
X – μ = L     F + ε 
      (px1)      =(pxm)(mx1)  (px1) 
The coefficient lij is called factor loading of the ith variable on the jth factor, so the matrix L is the 
matrix of factor loadings. The ith specific factor εi is associated only with variable Xi. The p 
deviations X1 – μ1, X2 – μ2, ..., Xp – μp are expressed in terms of p + m random variables F1, F2, ..., 
Fm, ε1, ε2, ..., εp which are unobservable. 
Moreover it is assumed that: 
E(F) = 0,   Cov(F) = E[FF’] = I 
      (mx1)
                                                    
(mxm) 
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E(ε) = 0,  Cov(ε) = E[εε’] = Ψ = 
(px1)                                                 (pxp) 
 
 
and that F and ε are independent, so: 
Cov (ε, F) = E(εF’) = 0 
                                            (pxm) 
The model with these assumptions constitutes the orthogonal factor model. If the matrix Cov(F) 
was not diagonal and consequently the factors were not independent but correlated, we would 
obtain the oblique model that presents additional estimation difficulties.  
The orthogonal factor model implies the following covariance structure for X: 
(X – μ) (X – μ)’ = (LF + ε)(LF + ε) 
                                                 = LF(LF)’+ ε(LF)’ + LFε’ + εε’ 
so that 
Σ = Cov (X) = E(X – μ) (X – μ)’ 
   = LE(FF’)L’ + E(εF’)L’ + LE(Fε’) + E(εε’) 
= LL’ + Ψ      (*) 
given that according to the previous assumptions Cov(F)=0, Cov(ε), and Cov(ε,F) = E(ε,F’)= 0.  
Moreover, (X – μ)F’= (LF+ ε)F’ = LFF’ + εF’, so  
Cov(X, F) =E(X – μ)F’ = LE(FF’) + E(εF’)= 
= L       (**) 
given that Cov(F)=0 and E(ε,F’)= 0. 
The equations (*) and (**) imply that 
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The model X – μ = L F + ε is linear in the common factors, and the assumption of linearity is 
inherent in the formulation of factor model. In fact, if the relation is not linear the covariance 
structure may not be adequate (e.g., if x1- μ1=l11F1F3+ ε1 and x2- μ1=l21F2F3+ ε2). 
The last equations are useful to see the Var(Xi) = ii as a portion of variance of the ith variable 
contributed by the m common factors, called ith communality, and a portion of the specific ith 
factor, called the uniqueness, or specific variance: 
iimiiii lll  
22
2
2
1 ...  
               Var (Xi) =  communality             + specific variance 
Indicating the communality with hi
2
, 222
2
1
2 ... imiii lllh  we obtained: 
iiii h  
2     i =1, 2, …, p 
where the ith communality is the sum of squares of the loadings of the ith variable on the m 
common factors. 
The factor model assumes that the 2/)1(2/)1(  ppppp  variances and covariances for X 
can be reproduced from the pm factor loadings lij and the p specific variances  i. When m=p any 
covariance matrix can be reproduced exactly, but is when p is small relative a m that factor analysis 
is most useful because the factor model can provide a simple explanation of the covariation in X 
with fewer parameters than the p(p+1)/2 parameters in Σ (e.g., if p=12 and want to describe the 
structure with 2=m factors, we will be able to describe the entire covariance with 36 parameters 
instead of 78). 
When m > 1, there is not a unique solution to the equation Σ = LL’ + Ψ. In fact, let T be any m x m 
orthogonal matrix so that TT’ = T’T = I, the factor model can be written as: 
X – μ = LF + ε = LTT’F + ε = L*F* + ε 
where 
L
*
 = LT  and  F
*
 = T’F 
Since 
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E(F
*
) = T’E(F) = 0 
and 
Cov(F
*
) = T’Cov(F)T = T’T = I 
     (m x m)
 
It is impossible on the basis of observation on X, to distinguish the loadings L from the loadings L
*
. 
That is, the factors F and F
*
 = T’F have the same statistical proprieties, and even if the loadings L* 
are different from the loadings L, they both generate the same covariance matrix, that is 
Σ=LL’+ Ψ=LTT’L+ Ψ=(L*)(L*)’+ Ψ 
This ambiguity provides the rationale for the factor rotation, since orthogonal matrices correspond 
to rotations (and reflections) of the coordinate system for X.  
Fcator loading L are determined only up to an orthogonal matrix T. This, the loadings L*=LT and L 
both give the same representation. The communalities, given by the diagonal elements of 
LL’=L*L*’ that is 222
2
1 ... imii lll   are not affected by the choice of F. This means that given m, 
for each choice of T and consequently F and L, the variance of Xi explained by m factors is always 
the same ( 222
2
1 ... imii lll  ) for each i. 
We do impose conditions if we want to uniquely estimate L and Ψ. So we generally fix the rotation 
(T) according to a criterion that facilitate the interpretation of factors. Once the loadings and 
specific variances ( i ) are obtained, factors are estimated. 
Model estimation 
Let S be the sample covariance matrix of n observations x1,x2,…,xn on p variables. It is an estimator 
of the unknown population covariance matrix Σ. If the off-diagonal elements of S are small or those 
of the sample correlation matrix R are essentially zero, the variables are not related and thus a FA 
should not be performed. In such a situation, the uniqueness play a dominant role, while the major 
purpose of FA is to determine a few important common factors, that adequately describe the 
phenomenon under consideration. 
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If Σ appears to deviate significantly from a diagonal matrix, then a FA can be applied, and the initial 
problem is to estimate the factor loadings lij and the specific variances ψi. 
Among the methods of parameter estimation, the most common are the principal component 
method. Let , , …, , with 1 ≥ 2 ≥ … ≥ p. be the eigenvalue-eigenvector 
pairs of the matrix S. Since this matrix is symmetric, it can be written as the following spectral 
decomposition 
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Since we are interested to describe S in terms of m<p common factors, S can be approximated as 
follows 
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 j=1,2,…,n 
whose sample covariance matrix is the sample correlation matrix R of the observations x1,x2,…,xn. 
The principal component FA of the sample correlation matrix is obtained starting with R in place of 
S.  
Choice of the number of factors 
If the number of common factors is not determined by a priori considerations, the choice of m can 
be based on the estimated eigenvalues. In fact, it is possible to show that the sum of squared entries 
of the residual matrix 'ˆˆLLS  +
~
 is ≤ pm
2
1
2 ˆ...ˆ   , and this implies that a small value for the 
sum of the squares of the eigenvalues gives a small value for the sum of squared errors of 
approximation. The contribution to the total sample variance from the first common factor is 
2
1
2
21
2
11
ˆ...ˆˆ plll  = 11111 ˆ
ˆ'ˆˆ  







 ee  since 1ˆe  has unit length. Proportion of total sample 
variance due to j-th factor is equal to 
p
jˆ
 if the variables are standardized. 
The choice of the number of factors  was based on three main criteria. The first one is to retain 
those factors with eigenvalues greater than 1.00. The second criterion is to add successive factors 
until the cumulative percentage of variance explained by the retained factors is satisfactory. To 
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terminate the factor extraction process, we considered 75-80% to be a valid threshold for the 
cumulative variance extracted. The third one, suggested by Cattell [37], is to plot, by the option 
SCREE in SAS, the extracted factors against their eigenvalues in descending order of magnitude to 
identify distinct breaks in the slope of the plot, called “scree plot”. To determine where the break 
occurs, a straight line should be drawn with a ruler through the lower values of the plotted 
eigenvalues. That point where the factors curve above the straight line drawn through the smaller 
eigenvalues identifies the optimal number of factors to retain. 
Finally, to determine the number of factors to retain, a researcher should not be based only on 
statistical criteria, but also on subjective motivations. In fact, the other criterion to take in account is 
factor interpretability. 
Factor rotation 
All factor loadings obtained from the initial loadings by an orthogonal transformation have the same 
ability to reproduce the covariance (or correlation) matrix. If  is the p x m matrix of estimated 
factor loadings obtained by any method, then 
TLL ˆ*ˆ     where TT’ = T’T = I 
is a p x m matrix of “rotated” loadings. The estimated covariance (or correlation) matrix remains 
unchanged, since: 
 ˆ'ˆˆˆ'ˆ'ˆˆ'ˆˆ **LLLTTLLL  
This equation indicates that also the residual matrix remains unchanged:  
 ˆ'ˆˆˆ'ˆˆ **LLSLLS nn  
Moreover the specific variances , and so the communalities , are unchanged as well. Thus, 
from a mathematical point of view, it doesn’t make any difference whether Lˆ  or *Lˆ  is obtained. 
Since the original loadings may not be easily interpretable, it is usual practice to rotate them until a 
“simple structure” is obtained. Ideally, it is desirable to have a pattern of loadings such that each 
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variable loads highly on a single factor and has small-to-moderate loadings on the remaining 
factors. This solution is computed by selecting the orthogonal transformation T that maximizes the 
variance V of factor loadings, that is to find l
~
such that  
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is maximized. 
This simplest case of rotation is an orthogonal rotation in which the angle between the reference 
axes of factors are maintained at 90 degrees; this implies that the rotated factors remain 
uncorrelated. Other forms of rotation, indicated as oblique rotations, allow the angle between the 
reference axes to vary, i.e., factors are allowed to be correlated with each other. Orthogonal rotation 
procedures are more commonly used than oblique rotation procedures, and should be performed 
when the common factors are assumed to be independent. This is a crucial aspect in nutritional 
epidemiology, where one may deal with severe multicollinearity problems, and so I used forms of 
orthogonal rotation. In other situations where the correlations between the underlying constructs are 
not assumed to be zero, oblique rotations may yield simpler and more interpretable factor solutions. 
Measures of sampling adequacy 
In order to test whether the sample covariance matrix is factorable, I used measures of sampling 
adequacy that compare the simple and partial correlation coefficients either overall or for single 
variables. The overall measure, called Kaiser-Meyer-Olkin statistic (KMO), is defined as follows 
[38]: 
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where  are the sum over all variables in the matrix when variable i  variable j, rij is the 
Pearson correlation coefficient between i and j, and aij the partial correlation coefficient between i 
and j. Individual measures of sampling adequacy are computed using only the simple and partial 
correlation coefficients involving the specific variable under consideration. The overall and 
individual measures range between 0 and 1. Smaller values indicate that the squared correlation 
coefficient is small relative to the squared partial correlation coefficient and therefore a FA may be 
imprudent. If the sum of the squared partial correlation coefficients is small compared with the sum 
of the squared correlation coefficients, the measures approach 1. 
On the contrary, if the off-diagonal elements sample correlation matrix are very small, the variables 
are not related and thus a FA should not be performed. To test such a situation, we used Bartlett's 
test of sphericity that tests the null hypothesis that the correlation matrix is an identity matrix. It is a 
chi-square test [38], whose statistic is defined as follows: 
  R
k
N log
6
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where χ2 is the calculated chi-square value for Bartlett’s test, N is sample size, k is the number of 
variables in the matrix and |R| the determinant of the correlation matrix. The degrees of freedom for 
this chi-square are k(k–1)/2. Larger values of the test suggest that the null hypothesis should be 
rejected.  
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4. RESULTS - FLAVONOIDS AND CANCER RISK 
 
4.1 Cancers at the upper aerodigestive tract 
4.1.1 Flavonoids and oral and pharyngeal cancer  
Data on oral and pharyngeal cancer (Figure 1 – Appendix 1) showed that total flavonoids were 
inversely related to the risk of this neoplasm [39]. The ORs for the highest versus the lowest 
quintile of all classes of flavonoid intake were below unity. The OR was 0.51 for flavanones, 0.62 
for flavonols, and 0.56 for total flavonoids, with significant inverse trend in risk. No significant 
association emerged for other classes of flavonoids. The ORs were consistent across strata of age, 
sex, education, BMI, tobacco smoking and alcohol intake. After allowance for vegetable and fruit 
consumption, the inverse relations with total flavonoids and flavanones remained significant, 
whereas that with flavonols became non significant. None of the associations was significant after 
further allowance for vitamin C, probably on account of the high correlation between these 
compounds. 
4.1.2 Flavonoids and esophageal cancers  
Flavanones were significantly inversely associated with esophageal cancer risk (OR, 0.38) (Figure 1 
– Appendix 1) [40]. The inverse relation tended to be stronger in subjects who drank ≥ 6 drinks of 
alcoholic beverages per day. After allowance for fruit intake or vitamin C, the association of 
flavanones with esophageal cancer remained inverse, though non-significant, suggesting that 
flavanone may explain, together with vitamin C, the protective effect of citrus fruits on esophageal 
cancer, since citrus fruit accounts for 90% of flavanone intake. 
4.1.3 Flavonoids and laryngeal cancers  
Significant inverse relations were found between flavanols (OR,0.64), flavanones (OR, 0.60), 
flavonols (OR, 0.32), and total flavonoids (OR, 0.60) and laryngeal cancer risk (Figure 1 – 
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Appendix 1), although the trends in risk were significant only for flavanones and flavonols [41]. 
The estimates changed little after controlling for vegetable, fruit, and vitamin C intake.  
 
4.2 Cancers at the digestive tract 
4.2.1 Flavonoids, proanthocyanidins and stomach cancer 
Although all ORs were below unity, no significant association emerged for any class of flavonoids 
(Figure 2 – Appendix 1) [42]. There was an inverse trend in risk for flavonols, but the continuous 
OR (0.88) was not significant. There were inverse associations between all classes of 
proanthocyanidins and stomach cancer risk, with significant trend in risk: the ORs were 0.44 for 
monomers and dimers combined, 0.36 for polymers with three or more mers, and 0.34 for total PAs. 
These estimates did not change when I adjusted for total flavonoid intake, and for fruit and 
vegetable consumption. 
4.2.2 Flavonoids, proanthocyanidins and colorectal cancer 
Significant inverse trend in the risk of colorectal cancer was found with increasing intake of 
anthocyanidins (OR, 0.67), flavonols (OR, 0.64), flavones (OR, 0.78), and isoflavones (OR, 0.76) 
(Figure 3 – Appendix 1) [43]. The estimates did not substantially differ for colon and rectal cancers. 
After allowance for fruit and vegetables consumption, dietary fiber, or certain micronutrients 
including vitamin C, the associations with flavonoids did not change by more than 10%. 
A significant trend of decreasing colorectal cancer risk emerged also with increasing intake of 
proanthocyanidins, for all classes, except for monomers [44]. The OR for the highest versus the 
lowest quintile of intake was 0.82 for monomers and dimers combined, and 0.74 for all polymers 
with three or more mers (0.84 for trimers, 0.80 for 4-6 mers, 0.79 for 7-10 mers, 0.69 for polymers 
more than 10 mers). Adjustments for other classes of flavonoids did not substantially modify the 
associations between proanthocyanidins and colorectal cancer risk. The inverse associations 
appeared to be stronger for rectal than for colon cancer. 
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4.2.3 Flavonoids and liver cancer 
Table 1 (Appendix 1) shows multiple ORs and corresponding 95% CI of six classes of flavonoids 
among hepatitis B (HBV) and/or C (HCV) virus postive, HBV and HCV negative HCC cases, and 
cholangiocarcinoma (CAC) cases [15]. There were no distinct patterns with respect to either HCC 
virus positive or HCC virus negative in relation to total flavonoids or any class of flavonoids, with 
the exception of flavones. For the latter class, there were inverse associations with respect to both 
HCC virus positive category (P-trend, 0.049) and HCC virus negative category (P-trend, 0.084). If 
we ignore the distinction into virus positive or negative and evaluate HCC cases as a total, the 
inverse association with flavones was more evident and statistically significant (P-trend, 0.023). 
With respect to the generally rare CAC, there were apparently strong inverse associations with 
flavan-3-ols and anthocyanidins, as well as total flavonoids. 
4.2.4 Flavonoids, proanthocyanidins and pancreatic cancer 
Inverse associations were found with significant trend in risk for isoflavones (OR, 0.40) and 
flavanones (OR, 0.68), and with a borderline significant trend in risk for flavonols (OR, 0.69) 
(Figure 4 - Appendix 1) [45]. No meaningful association emerged for other flavonoids, including 
anthocyanidins (OR, 0.83), flavanols (OR, 0.63), and flavones (OR, 0.88). All the ORs were below 
unity for all proanthocyanidins with a significant trend in risk for polymers with three or more mers 
and total proanthocyanidins. The ORs were similar in all classes of polymers with three or more 
mers and in their combinations (OR, 0.41). After adjustment for fruit and vegetables, the OR for 
flavonoids and proanthocyanidins did not substantially change. After adjustment for vitamin C or 
folate, the associations for isoflavones and proanthocyanidins weakened, whereas the associations 
with other classes of flavonoids disappeared. 
 
4.3 Hormone-related cancers 
4.3.1 Flavonoids and breast cancer 
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A reduced risk of breast cancer was found for increasing intake of flavones (OR, 0.81, p-
trend=0.02), and flavonols (OR, 0.80, p-trend, 0.06) (Figure 5 – Appendix 1) [46]. 
4.3.2 Flavonoids and ovarian cancer 
Flavonols (OR, 0.63) and isoflavones (OR, 0.51) were inversely related to ovarian cancer with a 
significant trend in risk (Figure 5 – Appendix 1) [47]. Further adjustments for fruit and vegetable 
intake did not materially modify these associations.  
4.3.3 Flavonoids and prostatic cancer 
No association was found between any of the analyzed class of flavonoids and prostate cancer risk 
[48]. 
 
4.4 Other cancers 
4.4.1 Flavonoids and renal cancer 
Flavonols (OR, 0.69) and flavones (OR, 0.68) were significantly inversely related to the risk of 
renal cancer [49] (Figure 5 – Appendix 1). Allowance for vegetable and fruit consumption only 
partly explained the inverse relation with these flavonoids. 
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5. RESULTS - TAC AND CANCER RISK 
 
5.1 TAC, flavonoids, proanthocyanidins and colorectal cancer 
Table 1 (Appendix 2) shows the mean daily intake and the upper cut off points of quintiles of TAC 
intakes among controls. The mean daily intake was 4.47 mmol for TEAC, 4.56 mmol for TRAP, 
11.45 mmol for FRAP. 
The three indexes were strongly correlated: the correlation was 0.97 between TEAC and TRAP, 
0.99 between TEAC and FRAP, and 0.98 between TRAP and FRAP. For this reason, I would have 
expected to obtain similar results; since I analyzed TAC for the first time, I present results on the 
three indexes. 
Table 2 (Appendix 2) gives the correlations of TEAC, TRAP and FRAP with selected covariates 
including fruit, vegetable, flavonoids and PAs, among controls. High correlation was found between 
the three TAC indexes and flavonoids (~0.60), anthocyanidins (~0.85) and proanthocyanidins 
(~0.60). 
Table 3 (Appendix 2) gives the ORs of colorectal cancer according to quintiles of TAC. We found 
inverse associations between all three measures of TAC and colorectal cancer risk, with OR 
estimates very similar among the three measure of TAC, as expected. The OR for the highest versus 
the first quintile was 0.78 (95% CI, 0.63-0.96; p-trend, 0.002) for TEAC, 0.74 (95% CI, 0.60-0.92; 
p-trend, 0.001) for TRAP and 0.78 (95% CI, 0.63-0.96; p-trend, 0.003) for FRAP. ORs did not 
materially change after adjustment for fruit and vegetables. When I separately studied the cancer of 
rectum and of colon, I found that the OR was 0.89 (95% CI, 0.70-1.15; p-trend, 0.15) for TEAC, 
0.82 (95% CI, 0.63-1.05; p-trend, 0.037) for TRAP and 0.85 (95% CI, 0.66-1.09; p-trend, 0.13) for 
FRAP for colon cancer; and 0.65 (95% CI, 0.48-0.88; p-trend, 0.001) for TEAC, 0.66 (95% CI, 
0.49-0.90; p-trend, 0.002) for TRAP and 0.70 (95% CI, 0.52-0.95; p-trend, 0.002) for FRAP for 
rectal cancer. 
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The OR for FRAP became 1.09 (95% CI, 0.82-1.46) adjusting for anthocyanidins, 0.79 (95% CI, 
0.64-0.98) adjusting for flavones, 0.90 (95% CI, 0.72-1.13) adjusting for flavonols, 0.88 (95% CI, 
0.69-1.11) adjusting for PAs, 0.87 (95% CI, 0.69-1.08) adjusting for proanthocyanidins with more 
than 10 mers. Similar trend was found in the estimates of ORs for TEAC and TRAP. 
Conversely, after adjusting for FRAP, the OR was 0.63 for anthocyanidins (95% CI, 0.48-0.84), 
0.80 for flavones (95% CI, 0.67-0.95), 0.67 for flavonols (95% CI, 0.55-0.81), 0.81 for total 
proanthocyanidins (95% CI, 0.65-0.99) and 0.73 for proanthocyanidins with more than 10 mers 
(95% CI, 0.60-0.89). I obtained similar OR estimates adjusting for TEAC and TRAP rather than 
FRAP. 
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6. RESULTS - STATISTICAL TECHNIQUES TO FACE THE PROBLEM 
OF HIGH COLLINEARITY AMONG DIETARY FACTORS 
 
6.1 Collinearity within flavonoids in colorectal cancer data 
The median, mean, standard deviation, maximum and minimum of 34 single classes of flavonoids 
in 1953 cases and 4154 controls from the study on colorectal cancer are given in Table 1 (Appendix 
1). The distributions were generally right-skewed given the presence of outliers. 
I applied FA to the 34 single flavonoids, in order to explain the variance of the entire structure of 
flavonoids with a smaller set of variables, address the problem of collinearity within flavonoids and 
detect which flavonoids is associated with cancer risk independently from other flavonoids. A 
different approach consists in grouping the 8 major classes of flavonoids - that is according to their 
chemical structure - and inserting them in FA instead of the 34 single flavonoids. This is a classical 
approach since previous studies – including my studies – used these 8 major classes to investigate 
the relation between flavonoids and cancer risk behind the assumption that flavonoids with similar 
chemical structure have similar effect on the disease. Although this is an acceptable assumption, it 
easy to see from Table 1 (Appendix 3) and Table 2 (Appendix 3) that some flavonoids have a very 
different distribution than other flavonoids belonging to the same class, and since some chemical 
differences - not in the main structure but in the last ring [4] occurred in these flavonoids, I thought 
that exploiting the variance of all the 34 flavonoids was much better. For these reason, I started to 
analyze separately the 34 flavonoids and compared later on these results with those obtained by 
applying FA to the 8 classes of flavonoids. 
6.1.1 Factor analysis on 34 single flavonoids and proanthocyanidins  
The ORs for the highest versus the lowest quintile of flavonoid intake were described above and 
were reported in Figure 1 (Appendix 3). I found inverse association between some classes of 
flavonoids and colorectal cancer risk, but since the models included only the flavonoids under 
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investigation and not other flavonoids, the associations were not adjusted for the possible 
confounding of other flavonoids.  
I first standardized the 34 flavonoid variables so that their means were equal to 0 and their variances 
equal to 1, and then applied FA to these. I found that the correlation matrix was not singular, so 
there were linear dependencies in the correlation matrix, and some scoring coefficients equal to 0. I 
first tried excluding proanthocyanidins but I found again a not singular matrix. Possible high 
correlation values among items could have been attributed to duplication of subjects in the database, 
but I have preliminary cleaned the data before analysis, and I had enough subject per items. 
Therefore, in order to verify whether there were too strong correlations among some items, I 
analyzed the correlations between each couple of flavonoids computed among all subjects (Table 2 
– Appendix 3). I found that there were various flavonoids strongly associated with other flavonoids, 
especially belonging to the same classes, but not only. I started to group flavonoids with correlation 
coefficients higher than 0.90 and found that they had similar correlation coefficients with all other 
flavonoids. I first inserted one flavonoid as representative per one group of flavonoids in FA and 
used the Kaiser-Meyer-Olkin (KMO) test to verify whether the items were still too strongly 
correlated. In fact, specifying the option MSA in the proc factor, I obtained the total measure of 
sampling adequacy (MSA) and the MSA for each item, which were of great help to identify 
possible errors in grouping flavonoids and improve the choice of flavonoid groups. I did numerous 
attempts before detecting the groups of flavonoids to insert in the FA by using the same following 
procedure: 1) I identified the items with high correlation and with the lowest MSA, 2) I removed it 
from the list of items to be analysed, and 3) I rerun the test of matrices. I then identified the 
following 15 groups of flavonoids: 
1) S1: FL1, ISO-DAIDZEINA ~ FL2, ISO-GENISTEIN 
2) S3: FL3, ANTHO-Cyanidin ~ FL6 ANTHO-Pelargonidin 
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3) S4: FL4, ANTHO-Delphinidin ~ FL5, ANTHO-Malvidin ~ FL7, ANTHO-Peonidin, FL8, 
ANTHO-Petunidin ~ FL9 FLAVAN3-(+)-Catechin 
4) S10: FL 10, FLAVAN3-(-)-Epigallocatechin ~ FL12, FLAVAN3-(-)-Epicatechin 3-gallate ~ 
FL13, FLAVAN3-(-)-Epigallocatechin 3-gallate ~ FL14, FLAVAN3-Theaflavin ~ FL 15, 
FLAVAN3-Thearubigins ~ FL25 FLAVAN3-Theaflavin-3,3'-digallate ~ FL26, FLAVAN3-
Theaflavin-3'-gallate ~ FL27, FLAVAN3-Theaflavin-3-gallate ~ FL28, FLAVAN3-(+)-
Gallocatechin 
5) S11: FL11, FLAVAN3-(-)-Epicatechin 
6) S16: FL 16, FLAVA-Eriodictyol 
7) S17: FL17, FLAVA-Hesperetin ~ FL18, FLAVA-naringenin 
8) S19: FL19, FLAVONE-Apigenin 
9) S20: FL20, FLAVONE-Luteolin 
10) S21: FL21, FLAVONO-Isorhamnetin 
11) S22: FL22, FLAVONO-Kaempferol 
12) S23: FL23, FLAVONO-Myricetin 
13) S24: FL24, FLAVONO-Quercetin 
14) S29: FL29, PROANTHO-Monomers ~ FL30, PROANTHO-Dimers 
15) S31: FL31, PROANTHO-Trimers ~ FL32, PROANTHO-4-6mers ~ FL33, PROANTHO-7-
10mers ~ FL34, PROANTHO-Polymers 
In these groups, some classes of flavonoids were divided into various groups and one group was 
created by flavonoids belonging to different classes, as follows: 
Isoflavones: 1 group 
Anthocyanidins: 2 groups 
Flavan-3-ols: 3 groups 
Flavanones: 2 groups 
1 common group 
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Flavones: 2 groups 
Flavonols: 4 groups 
Proanthocyanidins: 2 groups. 
This grouping took into account the different distributions of flavonoids belonging to the same class 
without altering the entire structure of flavonoids that I wanted to explain through FA. Figure 2 and 
Figure 3 (Appendix 3) show the percentages of intake of each single flavonoid to which various 
food sources contributed, overall and according to the new grouping. I found that the grouping 
strongly depended on their major sources. This was not surprising, however, since the variance in 
flavonoids directly depends on the variance of food consumption from which their intake derives, 
but it was reassuring for keeping the control of the flavonoid structure.  
Once I resolved the problem of multicollinearity, I looked for the items that were not correlated 
strongly enough with the other items. In fact, since these items have not much shared common 
variance and would yield as many factors as items in FA, they should be dropped out from FA. I 
was not able to perform the Bartlett’s test of sphericity in SAS in order to test the null hypothesis 
that the correlation matrix is an identity matrix (i.e. that there is no relationship among the items), 
and to verify whether exclude or not some factors. However, since the statistic χ2 is influenced by 
the sample size, with larger sample sizes resulting in larger values of Bartlett’s test, this test would 
have not been sufficiently informative for studies with large sample size as this study. In fact, it is 
rare that Bartlett’s test is too small to reject the null hypothesis that the matrix should not be factor 
analyzed, and this test is used only as a minimum standard for assessing the quality of the 
correlation matrix. I only excluded the group of isoflavones from FA, since their correlation 
coefficients with all other flavonoids were virtually identical to zero (Table 2 – Annex 3), and 
remained with sufficient numbers of significant correlations among other items to explain the use of 
FA. 
28 
Thus, applied FA to 14 groups of flavonoids by inserting one flavonoid as representative per one 
group, but I did not obtain acceptable values for KMO test. When I inserted the sum of flavonoids 
(instead of a representative flavonoid) per each group, I obtained a total MSA equal to 0.61, a 
“middling” value according to Kaiser’s criteria [38]. Higher values of total MSA (~ 0.67) and of 
minimum MSA per item (>0.38 versus 0.27) were obtained after exclusion of proanthocyanidins 
with three or more mers, but I judged that this class of flavonoids was essential in describing the 
entire structure in an understandable manner.  
Once I verified that the correlation matrix was factorable, my aim was to condense the variance that 
was shared among the items to determine the number of initial subsets or factors that appear to 
represent the dimensions of the “construct flavonoids”. I identified four factors that satisfy the three 
main criteria used in selecting the number of factors to retain in a FA: 
1. The eigenvalues > 1 criteria 
Eigenvalues of correlation matrix: Total = 14  Mean = 1 
 Eigenvalue Difference Proportion Cumulative proportion 
1 5.51275370 3.08424417 0.3938 0.3938 
2 2.42850953 0.46184863 0.1735 0.5672 
3 1.96666090 0.81124314 0.1405 0.7077 
4 1.15541776 0.18323795 0.0825 0.7902 
5 0.97217981 0.14972191 0.0694 0.8597 
6 0.82245790 0.22934382 0.0587 0.9184 
7 0.59311408 0.33708399 0.0424 0.9608 
8 0.25603009 0.11014972 0.0183 0.9791 
9 0.14588037 0.07932734 0.0104 0.9895 
10 0.06655303 0.02914401 0.0048 0.9943 
11 0.03740902 0.01383479 0.0027 0.9969 
12 0.02357423 0.00769616 0.0017 0.9986 
13 0.01587806 0.01229653 0.0011 0.9997 
14 0.00358153  0.0003 1.0000 
 
 
The four eigenvalues grater than 1 and corresponding measures are highlighted in the Table above. 
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2. The criteria of cumulative percentages of variance extracted > 75% 
 
 
 Factor1 Factor2 Factor3 Factor4 
s3 0.31576 0.39937 0.80247 0.01907 
s4 0.71535 -0.60604 0.00564 -0.06112 
s10 0.31053 0.39036 -0.41660 0.63707 
s11 0.85434 -0.27684 0.07383 0.19181 
s16 0.18005 0.37859 0.82842 0.14920 
s17 0.29569 0.10271 0.30942 0.06323 
s19 0.80797 -0.52229 0.02215 0.03270 
s20 0.38018 0.49241 -0.22161 0.33862 
s21 0.49586 0.51454 -0.08459 -0.62416 
s22 0.63625 0.59302 -0.37128 0.07672 
s23 0.81469 0.08105 -0.28050 -0.27051 
s24 0.80328 0.38657 -0.09857 -0.26705 
s29 0.85713 -0.47696 0.03637 0.09202 
s31 0.68079 -0.06051 0.27804 0.13514 
 
 
Variance explained by each factor 
Factor1 Factor2 Factor3 Factor4 
5.5127537 2.4285095 1.9666609 1.1554178 
 
 
Item communality (h
2
): Total = 11.063342 
s3 s4 s10 s11 s16 s17 s19 s20 
0.9035240 0.88277088 0.82822383 0.84877181 0.88428782 0.19771488 0.92716240 0.55077815 
        
s21 s22 s23 s24 s29 s31 
0.90735313 0.90021642 0.82213962 0.87572683 0.97195881 0.56271330 
 
The percentage of variance explained was 11.063342/14*100=79%. 
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3. The scree plot criteria 
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Using the Cattel criteria [38], four factors remain above that line that account for the maximum 
amount of variance in the 14 items.  
31 
According to another criteria that factor extraction should be continued until the last factor accounts 
for only a small portion of the explained variance (less than 5%), I considered also the solution with 
6 factors. In fact, the sixth factor had eigenvalue equal to 0.82 and explained 5.9% (=0.82/14*100) 
of the total variance, whereas the seventh factor had eigenvalue 0.59 and explained 4.2% 
(0.59/14*100) of the total variance.  
In both solutions, the rate of the numbers of factors and the numbers of items remained between ½ 
and 1/4.  
I then applied a Varimax rotation to improve the meaningfulness and interpretation of the generated 
factors, and obtained the following rotated factor pattern for the solution with four factors. 
 
 Factor1 Factor2 Factor3 Factor4 
s3 0.02526 0.15350 0.93762 -0.01398 
s4 0.92357 0.10304 -0.05727 -0.12602 
s10 0.06221 -0.02233 -0.05727 0.90586 
s11 0.85993 0.13311 0.19537 0.23109 
s16 -0.05189 -0.01933 0.93867 0.01124 
s17 0.18318 0.08013 0.39230 0.06198 
s19 0.95533 0.11795 0.02426 0.00355 
s20 0.02494 0.22701 0.12750 0.69453 
s21 -0.00524 0.94072 0.14756 0.02454 
s22 0.12785 0.61550 0.05700 0.70836 
s23 0.54507 0.68496 -0.06010 0.22862 
s24 0.35358 0.78151 0.21250 0.30789 
s29 0.97289 0.11838 0.07406 0.07706 
s31 0.59094 0.14631 0.40677 0.16321 
 
 
Variance explained by each factor 
Factor1 Factor2 Factor3 Factor4 
4.2807159 2.5037716 2.2204329 2.0584215 
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Item communality (h
2
): Total = 11.063342 
s3 s4 s10 s11 s16 s17 s19 s20 
0.90352402 0.88277088 0.82822383 0.84877181 0.88428782 0.19771488 0.92716240 0.55077815 
 
s21 s22 s23 s24 s29 s31 
0.90735313 0.90021642 0.82213962 0.87572683 0.97195881 0.56271330 
 
I highlighted the meaningful loadings (greater than 0.60) and red marked the loadings that were 
meaningful for more than one items and the items without a meaningful factor loading. I found that 
all the items were explained by some factors, with the exception of the groups S31 and S17 whose 
variance was only partially explained by factor 1 (factor loading, 0.59) and factor 3 (factor loading, 
0.39), respectively. The group S22 had meaningful loadings for both factor 2 and factor 4.  
Apart from these weaknesses that could be overcome (for example, S31 could be considered as 
explained by factor 1), it was difficult to interpret the meaningfulness of the four factors. In fact, it 
easy to see also from Figures 4 (Appendix 3) that the new grouping “proposed” by FA was not 
related to the class to which flavonoids belonged, neither to the foods from which flavonoids 
derived. The following table shows flavonoids by group and by factor with the corresponding major 
food sources. Factor 1 included anthocyanidins, a flavanol, a flavone and proanthocyanidins, factor 
2 represented flavonols (but not all flavonols), factor 3 included anthocyanidins and a flavanone, 
and factor 4 included flavanols, a flavone and a flavonol. Since each factor explains the variance in 
flavonoids deriving from more than one food and the same food was included in different factors, it 
is difficult to indicate a major food as representative of one factor. However, I found that wine was 
an important source for factor 1, various vegetables for factor 2, red fruit for factor 3 and tea for 
factor 4, as the following table shows. 
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Factor Group Flavonoids Major sources 
Factor 1 
 
S4 
FL4, ANTHO-Delphinidin 
FL5, ANTHO-Malvidin 
FL7, ANTHO-Peonidin 
FL8, ANTHO-Petunidin 
FL9 FLAVAN3-(+)-Catechin 
wine 
wine 
wine 
wine 
wine 
S11 FL11, FLAVAN3-(-)-Epicatechin apple 
S19 FL19, FLAVONE-Apigenin various vegetables 
S29 
FL29, PROANTHO-Monomers  
FL30, PROANTHO-Dimers 
wine 
wine 
Factor2 S21 FL21, FLAVONO-Isorhamnetin onion, mix salad 
S22 FL22, FLAVONO-Kaempferol mix salad/various 
vegetables  
S23 FL23, FLAVONO-Myricetin wine 
S24 FL24, FLAVONO-Quercetin apple/all  
Factor3 S3 FL3, ANTHO-Cyanidin 
FL6 ANTHO-Pelargonidin 
strawberry/cherry 
strawberry/cherry 
S16 FL 16, FLAVA-Eriodictyol fruit juice/jam 
Factor4 S10 FL 10, FLAVAN3-(-)-Epigallocatechin 
FL12, FLAVAN3-(-)-Epicatechin 3-gallate 
FL13, FLAVAN3-(-)-Epigallocatechin 3-gallate 
FL14, FLAVAN3-Theaflavin 
FL 15, FLAVAN3-Thearubigins 
FL25, FLAVAN3-Theaflavin-3,3'-digallate 
FL26, FLAVAN3-Theaflavin-3'-gallate 
FL27, FLAVAN3-Theaflavin-3-gallate 
FL28, FLAVAN3-(+)-Gallocatechin 
tea 
tea 
tea 
tea 
tea 
tea 
tea 
tea 
tea 
S20 FL20, FLAVONE-Luteolin spinach/greens 
S22 FL22, FLAVONO-Kaempferol salad/tea/other vegetables 
 
 
 
The following tables show the results of the solution with six factors after Varimax rotation.  
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 Factor1 Factor2 Factor3 Factor4 Factor5 Factor6 
s3 0.05035 0.16712 0.00745 0.96312 0.10531 0.07554 
s4 0.97793 0.07832 -0.07646 -0.01092 0.02718 0.00976 
s10 0.08920 -0.03238 0.93169 -0.01717 -0.06295 -0.00294 
s11 0.69572 0.11637 0.18285 0.05039 0.61827 0.07633 
s16 -0.01754 -0.00418 0.03592 0.97896 0.05654 0.07200 
s17 0.08757 0.07270 0.02819 0.13002 0.10866 0.97829 
s19 0.97224 0.09319 0.03889 0.03263 0.13485 0.05973 
s20 -0.07014 0.22549 0.65974 0.04819 0.29002 0.02296 
s21 0.00465 0.94277 0.02678 0.12062 0.05535 0.02740 
s22 0.14650 0.60691 0.72803 0.05549 0.01790 0.05430 
s23 0.61242 0.66637 0.27552 -0.02846 -0.04874 0.04846 
s24 0.23762 0.77605 0.26619 0.08177 0.44091 0.08168 
s29 0.91466 0.09547 0.07888 0.02115 0.34520 0.05358 
s31 0.31737 0.14276 0.05688 0.16075 0.88149 0.11452 
 
 
Variance explained by each factor 
Factor1 Factor2 Factor3 Factor4 Factor5 Factor6 
3.7993355 2.4464412 2.0332080 1.9606274 1.6116935 1.0066740 
 
 
Item communality (h
2
): Total = 12.857980 
s3 s4 s10 s11 s16 s17 s19 s20 
0.97491493 0.96927215 0.88132343 0.92162955 0.96836367 0.99951312 0.97826833 0.57798445 
 
s21 s22 s23 s24 s29 s31 
0.90791854 0.92616910 0.90054915 0.93734282 0.97441558 0.94031477 
 
 
The total variance explained by six factors was equal to 91.8% (=12.86/14*100) and all flavonoids 
were related to at least one factor, but some factors were strongly correlated with the same group of 
flavonoids (factor1 and factor 2 with S23 and factor 2 and factor 3 with s22) making again the 
solution difficult to interpret. Moreover, factor 6 explained only the variance of group S17 and this 
was not performing. I then decided to analyze also the solution with five factors: the results follow. 
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 Factor1 Factor2 Factor3 Factor4 Factor5 
s3 0.06204 0.16488 0.00941 0.95951 0.15072 
s4 0.97226 0.09927 -0.04150 0.01004 0.00049 
s10 0.09554 -0.02572 0.92085 -0.00997 -0.09806 
s11 0.78637 0.12178 0.19661 0.03374 0.45775 
s16 -0.00942 -0.00628 0.03634 0.97683 0.11231 
s17 0.03826 0.06511 0.00840 0.13003 0.68871 
s19 0.97369 0.10590 0.02076 0.03140 0.05752 
s20 -0.02576 0.21975 0.68277 0.03649 0.24761 
s21 -0.00113 0.94134 0.02736 0.11951 0.07643 
s22 0.14661 0.61183 0.71919 0.05915 0.01713 
s23 0.58534 0.67750 0.25236 -0.02310 -0.06419 
s24 0.29702 0.77578 0.27989 0.06994 0.37352 
s29 0.95191 0.10601 0.07435 0.01286 0.22029 
s31 0.45407 0.13866 0.09498 0.13350 0.72739 
 
 
Variance explained by each factor 
Factor1 Factor2 Factor3 Factor4 Factor5 
4.0915904 2.4680907 2.0309843 1.9366099 1.5208082 
 
 
Item communality (h
2
): Total = 12.048084 
s3 s4 s10 s11 s16 s17 s19 s20 
0.97449981 0.95696837 0.86747337 0.88252923 0.96825190 0.49700754 0.96401566 0.57776588 
 
s21 s22 s23 s24 s29 s31 
0.90700376 0.91686022 0.86997540 0.91279765 0.97159973 0.78133508 
 
The total variance explained by five factors was equal to 86% (=12.04/14*100), all flavonoids were 
related to at least one factor, only one item was correlated with two factors (S22 with factor1 and 
factor 2), and there was no factor correlated only with one item. This solution appeared then more 
convincing. Factor 1 and factor 2 were comparable to the same factors of the solution with four 
factors whereas factors 3 and factor 4 were interchangeable with the previous solution. In addition, 
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factor 5 explained the variance of those flavonoids that were not correlated to any factors in the 
solution with four factors., that is flavanones - mainly deriving from citrus fruit - and 
proanthocyanidins with three or more mers - mainly deriving from apples (Figure 3 - Appendix 3). 
This made the solution of five factor the best one for our aim to describe the entire “construct 
flavonoids”. 
This solution allows to study possible effects of interaction between flavonoids on cancer risk, 
besides evaluating the individual effect of a flavonoid or a class of flavonoids as previous studies 
did. I therefore examined the relation between the five factors and colorectal cancer risk. 
Figure 5 (Appendix 3) shows the ORs for colorectal cancer risk of the second and the third tertiles 
versus the lowest tertile of factors. I found that factor 2, factor 4 and factor 5 were inversely 
associated to the risk of colorectal cancer, whereas no meaningful association was found for factor 1 
and factor 3. The OR for highest versus the lowest tertile was 0.66 for factor 2, 0.84 for factor 4, 
and 0.85 for factor 5. The trend in risk was significant in all three factors also when considering 
quintiles instead of tertiles.  
Factor Group Flavonoids Major sources 
Factor2 S21 FL21, FLAVONO-Isorhamnetin onion, mix salad 
S22 FL22, FLAVONO-Kaempferol mix salad/various 
vegetables  
S23 FL23, FLAVONO-Myricetin wine 
S24 FL24, FLAVONO-Quercetin apple/all  
Factor4 S3 FL3, ANTHO-Cyanidin 
FL6 ANTHO-Pelargonidin 
strawberry/cherry 
strawberry/cherry 
S16 FL 16, FLAVA-Eriodictyol fruit juice/jam 
Factor5 S17 FL17, FLAVA-Hesperetin 
FL18, FLAVA-naringenin 
citrus fruit 
citrus fruit 
S31 FL31, PROANTHO-Trimers 
FL32, PROANTHO-4-6mers 
FL33, PROANTHO-7-10mers 
FL34, PROANTHO-Polymers 
apple 
apple 
apple 
apple 
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6.1.2 Factor analysis on 8 classes of flavonoids and proanthocyanidins 
I report here the results of FA applied to the 8 classes of flavonoids instead of the single flavonoids. 
As mentioned before, this method does not take into consideration the different variances in 
flavonoids belonging to the same classes, that we observed before.  
The total MSA was 0.57 with a minimum individual MSA of 0.34 (for isoflavones). I chose the 
solution with 4 factors according to the eigenvalue >1 and the cumulative percentages of variance 
extracted (82%) greater than 75% criteria.  
Eigenvalues of correlation matrix: Total = 8  Mean = 1 
 Eigenvalue Difference Proportion Cumulative 
1 3.29213112 2.08540145 0.4115 0.4115 
2 1.20672967 0.18122097 0.1508 0.5624 
3 1.02550870 0.02785415 0.1282 0.6905 
4 0.99765455 0.39757231 0.1247 0.8153 
5 0.60008223 0.13252372 0.0750 0.8903 
6 0.46755852 0.11099813 0.0584 0.9487 
7 0.35656039 0.30278556 0.0446 0.9933 
8 0.05377483  0.0067 1.0000 
 
After Varimax rotation, I obtained the following factors loading: 
 
 Factor1 Factor2 Factor3 Factor4 
iso -0.00349 -0.00208 -0.00391 0.99877 
antho 0.92454 0.07478 -0.05543 -0.01782 
flavan3 0.39486 0.72357 -0.08913 -0.02528 
flava -0.00462 0.03142 0.94873 -0.01094 
flavone -0.04212 0.91551 0.05338 -0.00220 
flavono 0.39272 0.65785 0.21065 0.02855 
prop 0.94942 0.23743 0.01525 -0.00631 
prott 0.59144 0.34748 0.40661 0.05041 
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Variance explained by each factor 
Factor1 Factor2 Factor3 Factor4 
2.4179174 1.9781806 1.1239148 1.0020112 
 
 
Item communality (h
2
): Total = 6.522024 
iso antho flavan3 flava flavone flavono prop prott 
0.99756576 0.86376143 0.68804949 0.90122503 0.84279159 0.63218465 0.95803527 0.63841082 
 
As expected, the variances in isoflavones and flavanones were explained each by one single factor 
not related to any other class. In fact, the maximum correlation coefficient with other classes of 
flavonoids was < 0.1 for isoflavones and 0.2 for flavanones. This could be not a performing 
solution, but when I applied the FA to all the classes of flavonoids excluding isoflavones and 
flavanones, I found that the best solution was with 2 factors, which were identical to the factor 1 
and factor 2 of this analysis. For this reason, I remained with this solution and estimated the ORs 
according to tertiles of factors.  
I found that only factor 4 was inversely associated to colorectal cancer risk: the ORs of the second 
and third tertiles were 0.83 and 0.74, respectively. This solution appeared poor compared to the 
solution that I found by inserting single flavonoids. 
 
6.2 Collinearity between flavonoids and wine in the oral and pharyngeal cancer data 
6.2.1 Computing the intake of flavonoids not deriving from wine  
I am interested to detect which flavonoids are related to the disease taking into account the possible 
influence of their major food source on the risk. The simplest way to address the problem of the 
high correlation between flavonoids and the food is to compute the intake of flavonoids excluding 
the intake deriving from the consumption of this food. Among major flavonoid food sources, the 
high consumption of wine in the Italian population gave a lot of problems in analyzing flavonoids 
and the risk of some cancers that are strongly related to alcohol consumption.  
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Here, I report an example for oral and pharyngeal cancer. I used data from the Italian case-control 
on oral and pharyngeal cancer, and analysed monomer and dimer proanthocyanidins and 
proanthocyanidins with three or more mers that are strongly contained in wine: seventy-five per 
cent of monomers and dimers and 25% of polymers with three or more mers derived by wine in our 
controls (Figure 6 - Appendix 3). I used a logistic model that included also alcohol intake (see 
Material and Method), and I found that the ORs for proanthocyanidins with and without the intake 
from wine were different (Figure 7 - Appendix 3). In particular, I found significant associations 
between proanthocyanidins without intake from wine and oral and pharyngeal cancer risk (OR, 0,64 
for monomers and dimers combined and OR, 0,71 for polymers with 3 or more mers), that were not 
significant when I considered also intake from wine.  
6.2.2 A FA application 
I applied FA by excluding from the beginning isoflavones and flavanones since their maximum 
correlation coefficients with other flavonoids was 0.2 (for FLAVA-Hesperetin with FLAVONO-
Quercetin). I inserted one flavonoid as representative per one group according to the first 
classification I did in the FA on 34 flavonoids (Figure 3 - Appendix 3), for a total of 12 flavonoids. 
The total MSA was quite low, 50%.  
I chose the solution with 3 factors according to the eigenvalue >1 and the scree plot observation 
criteria. 
Eigenvalues of correlation matrix: Total = 12  Mean = 1 
 Autovalore Differenza Proporzione Cumulativa 
1 5.05121425 2.65595497 0.4209 0.4209 
2 2.39525929 1.05400988 0.1996 0.6205 
3 1.34124941 0.39335237 0.1118 0.7323 
4 0.94789704 0.13948759 0.0790 0.8113 
5 0.80840945 0.19381226 0.0674 0.8787 
6 0.61459719 0.17246928 0.0512 0.9299 
7 0.44212791 0.26924642 0.0368 0.9667 
8 0.17288149 0.03893569 0.0144 0.9811 
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Eigenvalues of correlation matrix: Total = 12  Mean = 1 
 Autovalore Differenza Proporzione Cumulativa 
9 0.13394580 0.06999604 0.0112 0.9923 
10 0.06394976 0.03597513 0.0053 0.9976 
11 0.02797463 0.02748085 0.0023 1.0000 
12 0.00049378  0.0000 1.0000 
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The cumulative percentages of variance extracted was 73%. After Varimax rotation, I obtained the 
following factors loading: 
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 Factor1 Factor2 Factor3 
FL3 ANTHO-Cyanidin 0.08597 -0.05047 0.53572 
FL4 ANTHO-Delphinidin 0.93233 -0.05900 -0.03097 
FL10 FLAVAN3-(-)-Epigallocatechin 0.06783 0.89961 -0.17177 
FL11 FLAVAN3-(-)-Epicatechin 0.92925 0.13477 0.13998 
FL19 FLAVONE-Apigenin 0.14191 0.78343 0.00946 
FL20 FLAVONE-Luteolin -0.03924 0.65827 0.22353 
FL21 FLAVONO-Isorhamnetin 0.06836 0.19502 0.86956 
FL22 FLAVONO-Kaempferol 0.18645 0.83326 0.36436 
FL23 FLAVONO-Myricetin 0.77157 0.29180 0.33391 
FL24 FLAVONO-Quercetin 0.48820 0.37841 0.69061 
FL29 Proanthocyanidin-Monomers 0.97599 0.09539 0.01032 
FL31 Proanthocyanidin-Trimers 0.63749 0.03608 0.27023 
 
 
Variance explained by each factor 
Factor1 Factor2 Factor3 
3.9984566 2.8516824 1.9375840 
 
 
Item communality (h
2
): Total = 8.787723 
FL3 FL4 FL10 FL11 FL19 FL20 FL21 FL22 
0.29693548 0.87368405 0.84340436 0.90126614 0.63399627 0.48482703 0.79884468 0.86184960 
 
FL23 FL24 FL29 FL31 
0.79196192 0.85847874 0.96175717 0.48071752 
 
It is interesting to see that all and only the flavonoids contained in wine load significantly to the first 
factor, which explained 33.3% of the total variance and seems to condense the variance of wine 
consumption. In fact, the groups of flavonoids strongly correlated to factor 1 were: 
 FL4, ANTHO-Delphinidin ~ FL5, ANTHO-Malvidin ~ FL7, ANTHO-Peonidin, FL8, 
ANTHO-Petunidin ~ FL9 FLAVAN3-(+)-Catechin 
 FL11, FLAVAN3-(-)-Epicatechin 
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 FL23, FLAVONO-Myricetin 
 FL29, PROANTHO-Monomers ~ FL30, PROANTHO-Dimers 
 FL31, PROANTHO-Trimers ~ FL32, PROANTHO-4-6mers ~ FL33, PROANTHO-7-
10mers ~ FL34, PROANTHO-Polymers 
The other 2 factors are described below and explained respectively the 23.7% and 16.1% of the total 
variance.  
 
Factor Flavonoids Major sources 
Factor2 FL 10, FLAVAN3-(-)-Epigallocatechin 
FL12, FLAVAN3-(-)-Epicatechin 3-gallate 
FL13, FLAVAN3-(-)-Epigallocatechin 3-gallate 
FL14, FLAVAN3-Theaflavin 
FL 15, FLAVAN3-Thearubigins 
FL25, FLAVAN3-Theaflavin-3,3'-digallate 
FL26, FLAVAN3-Theaflavin-3'-gallate 
FL27, FLAVAN3-Theaflavin-3-gallate 
FL28, FLAVAN3-(+)-Gallocatechin 
tea 
tea 
tea 
tea 
tea 
tea 
tea 
tea 
tea 
FL19, FLAVONE-Apigenin various vegetables 
FL20, FLAVONE-Luteolin spinach/greens 
FL22, FLAVONO-Kaempferol salad/tea/other vegetables 
Factor3 FL3, ANTHO-Cyanidin 
FL6 ANTHO-Pelargonidin 
strawberry/cherry 
strawberry/cherry 
FL21, FLAVONO-Isorhamnetin onion, mix salad 
FL24, FLAVONO-Quercetin apple/all  
 
These 2 factors were slightly correlated to other flavonoids (e.g., the factors loading were around 
0.3 between factor 3 and FL22, FLAVONO-Kaempferol, FL23, FLAVONO-Myricetin and 
proanthocyanidins ≥ 3 mers), but were totally purified by the confounding of wine consumption. 
I computed the ORs for the oral and pharyngeal cancer risk according to tertiles of factors 1-3, 
using the previous model. Only the factor 3 was inversely related to the risk of this tumor, as shown 
in Figure 8 (Appendix 3). The OR for the highest versus the lowest tertile was 0.66 (95% CI, 0.51-
0.87). I computed also the ORs according to quintile of factors and obtained comparable results.  
Figure 9 – a) (Appendix 3) shows the distribution of subjects by levels of factor 1 and factor 3. 
There was not a clear trend although the χ2 test was significant. I obtained a similar result when I 
studied the distribution of subjects by levels of alcohol intake and factor 3 (Figure 9 - b). Figures 10 
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a) and b) (Appendix 3) show the ORs for oral cavity and pharyngeal cancer according to the various 
combination of levels of factor 1 and factor 3, and of alcohol habits and factor 3, comparing to the 
lowest levels. Test for interaction was not significant. However, this result shows better the effect of 
a diet rich in flavonoids in heavy alcohol drinkers, since the OR was 13 in high flavonoid consumer 
and 7 in low flavonoids consumers. These analyses are difficult using classical methods since high 
levels of alcohol intake were related to high levels of flavonoid intake. 
I obtained similar results when I added to these flavonoids an item equal to the sum of all 
flavonoids deriving from wine consumption, or directly an item for alcohol intake. I applied also the 
FA to all flavonoids without intake deriving from wine, but the results were difficult to interpret and 
to use.  
 
6.3 Collinearity between flavonoids and other biocative compounds contained in plant foods  
6.3.1 Residuals on TAC 
It is not easy to take into account the possible influence of other beneficial compounds contained in 
the same food sources of flavonoids. Among them, however, all the components with antioxidant 
properties can be measured trough the TAC, using the three assays TEAC, TRAP and FRAP. Also 
flavonoids contribute to the computation of these measures, together with other antioxidants like 
vitamin A and vitamin C. I computed then the residuals of flavonoids on TAC in order to evaluate 
the risk for high levels of flavonoids independently from high levels of TAC. I applied this 
technique to oral and pharyngeal cancer data.  
Given the high correlation between the three measures of TAC, I will show the results only for 
FRAP, which was inversely associated to the risk of oral and pharyngeal cancer. In Figure 11 
(Appendix 3), I reported the ORs for the highest versus the lowest quintile of flavonoid intake and 
residuals of flavonoids on FRAP for those classes that were inversely related to this tumor. I found 
that the association for flavanones and flavonols persisted after adjusting for FRAP, whereas the 
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association for proanthocyanidins with three or more mers disappeared. This was an interesting 
result, especially for flavanones, since this class was strongly correlated to vitamin C (r ~ 0.8), 
which was inversely related to oral and pharyngeal cancer risk too. The models including both 
flavanones and vitamin C were difficult to interpret, and the residual method allowed me to evaluate 
the risk of flavanones adjusting – though indirectly - for vitamin C. 
This result strengthens the hypothesis that flavanones and flavonols – but not proanthocyanidins - 
have a role in the oral and pharyngeal cancer prevention.  
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7. RESULTS - A METHOD TO TAKE INTO ACCOUNT THE OVER-
REPORTING OF CASES IN CASE-CONTROL STUDIES 
 
7.1 Residuals on fruit and vegetable consumption in the oral and pharyngeal cancer data 
A protective role of fruit and vegetable consumption on various cancer risk has been reported in 
numerous case-control studies but results on cohort studies were open to discussion [1]. The results 
from case-control studies can be in part explained by a recall bias of cases, who tend answer with 
more accuracy and report a higher intake of energy. Likely, the weak associations that I found in 
these studies reflect this bias, whereas the stronger associations, which I found especially for 
proanthocyanidins, show a more convincing protective effect of these compounds on cancer. To 
investigate this issue, I computed the residuals of flavonoids on fruit and vegetable consumption in 
all subjects of oral and pharyngeal cancer study, as a direct adjustment of a recall bias of cases. 
Figure 1 (Annex 4) shows the ORs for oral cavity and pharyngeal cancer, according to the highest 
versus the lowest quintile of flavonoid residuals on fruit and vegetables. No associations persisted 
after this adjustment.  
 
7.2 Residuals on water consumption in the oral and pharyngeal cancer data 
Although water does not differ in terms of cancer risk from case-control and cohort studies, like 
fruit and vegetables, the use of residuals on water rather than energy intake was considered to take 
into account the bias due to the over-reporting of cases in case-control studies.  
I calculated the intake of water from food and beverages using food database tables and information 
from our FFQ, and computed residuals on water in all subjects of oral and pharyngeal study. The 
ORs are reported in Figure 1 (Annex 4). The association between flavanones and flavonols did not 
substantially change, whereas the association for proanthocyanidins with three or more mers 
disappeared.  
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8. DISCUSSION 
8.1 Flavonoids and cancer risk 
Flavanones, which are flavonoids deriving mainly from citrus fruit, were the class most strongly 
associated with a reduced risk of neoplasms at the upper aerodigestive tract in these Italian studies. 
They have also been inversely related to gastric cancer in a Greek case-control study [14]. This is of 
interest, given the similarities in risk factors between various neoplasms of the upper aerodigestive 
tract (mainly tobacco, alcohol, as well as a diet poor in vegetables and fruit) [50, 51], and gastric 
cancer, too (i.e., tobacco, lower social class and various indicators of a poor diet) [52]. As was 
noted for esophageal and laryngeal cancers, the inverse relation between flavanones and stomach 
cancer persisted, albeit weaker, after allowance for vitamin C [14, 40, 41]. Data from Italy are also 
in agreement with those of a case control-study conducted in Uruguay that reported inverse 
relations between flavonoids and oral, esophageal, and laryngeal cancer risk. No specific 
information on types of flavonoids was given in that study. More recently, in a population-based 
case-control study from the USA [53], inverse associations in white men were observed between 
anthocyanidin intake and esophageal adenocarcinoma, and isoflavone intake and esophageal 
squamous cell carcinoma. However, none of these associations remained significant after adjusting 
for dietary fiber. To our knowledge, no other study investigated flavonoids in relation to the risk of 
cancer of the upper aerodigestive tract.  
 
Inverse associations between proanthocyanidins and cancer risk were found for pancreatic cancer. 
Further adjustment for fruit and vegetables, or vitamin C, did not materially change these 
associations. proanthocyanidins with three or more mers, which derived mainly from apples, were 
most strongly related to the risk of this cancer. These associations did not substantially change after 
adjustment for total flavonoid intake. There was little evidence that other flavonoids had a 
significant role on stomach cancer risk.  
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These results are in line with findings from previous studies in vitro [54] that showed superior 
radical scavenging properties of proanthocyanidins as compared with other flavonoids. 
proanthocyanidins may lead to oligomerization via phenolic coupling and enlargement of the 
number of reactive sites. 
This is the first epidemiological study to suggest that dietary proanthocyanidins have a favourable 
role on gastric cancer risk. 
With reference to colorectal cancer, a case-control study from Canada indicated an inverse 
association between dietary isoflavone intake and risk of colorectal cancer [55]. In a prospective 
study from Japan [56], intake of isoflavones (and soy foods) was inversely associated with the risk 
of proximal colon cancer in men, while another Japanese prospective study [57] showed a reduced 
risk of colon cancer with increased consumption of soy products (major sources of isoflavones) 
only among women. No other consistent associations, however, were reported from these Japanese 
prospective studies undertaken in populations characterized by a high consumption of isoflavone-
rich foods [56, 57]. In a case-control study in Japan, isoflavone intake has also been inversely 
associated to the risk of colorectal adenoma [58], and, together with flavonol intake, to the risk of 
advanced adenoma recurrence. A recent case-control study conducted in Sweden indicated a 
significant decreased risk of colorectal cancer for intake of anthocyanidins and flavonols [59], but 
not for isoflavones and flavones, as in the Italian data. In the Italian population, anthocyanidins 
were derived mainly from wine, red fruit, and onions, and flavonols from apples or pears, wine and 
mixed salads.  
I found that also proanthocyanidin intake was inversely associated with the risk of colorectal 
cancer. The inverse associations were apparently stronger for the classes of proanthocyanidins with 
higher degree of polymerization. A recent case-control study from Scotland found an inverse 
association of colorectal cancer risk with the intake of single flavanols, including catechins and 
epicatechins, and procyanidins (polymers of [epi] catechin) [60], but no other study has 
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systematically investigated proanthocyanidins. Studies in vitro and experimental animals suggest 
they have favorable effects on colorectal cancer [4, 61-67] and have larger antioxidant effects than 
flavanols [68, 69]. In this analysis, adjustment for flavanols and anthocyanidins, which were 
strongly correlated to proanthocyanidins, did not substantially modify the inverse relation between 
proanthocyanidins and colorectal cancer risk.  
Intake of flavones – but not of other flavonoids – was inversely related to HCC risk. Moreover, total 
flavonoids, flavan-3-ols and anthocyanidins may be strongly inversely associated with CAC. No 
epidemiological study has previously investigated the relation between flavonoids and primary liver 
cancer risk, and larger studies are needed for documentation of the strength of these associations. 
Isoflavones and proanthocyanidins with three or more mers were inversely related to the risk of 
pancreatic cancer, also after adjustment for fruit and vegetables consumption, and for vitamin C and 
folate intakes. Less strong associations were also found for flavanone and flavonol intakes that, 
however, disappeared after adjustment for other dietary micronutrients. The OR estimates were 
generally lower for women than men. This may be due to the fact that men drink more wine (a main 
source of flavonoids and PAs) than women, and this can reduce the inverse association between 
flavonoids and proanthocyanidins and pancreatic cancer in men, given the direct association 
between alcohol consumption and pancreatic cancer risk. 
In the four cohort studies that examined the relation between flavonoids and pancreatic cancer risk 
[70-73], only flavanols, flavones and flavonols have been studied. An association between flavonols 
(in particular, kaempferol) and pancreatic cancer was reported only in subgroups of population [70, 
71]. The risks, however, were not adjusted for other dietary factors. 
 
With reference to breast cancer, these findings are compatible with those of a case-control study 
from Greece [17], which found an inverse association between flavones and breast cancer risk. A 
recent case-control study from the USA on 1434 women of Long Island [16] reported results in line 
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with those from the Mediterranean populations. Among Italian women, flavone intake derived 
mainly from (aromatic) herbs, and flavonol intake from various common vegetables and fruits. 
Several epidemiological studies also found that dietary phytoestrogens are inversely associated with 
breast cancer risk [74]. The absence of any meaningful association with isoflavone intake in the 
Italian study may be due to the extremely limited intake of soya or soya products - and 
consequently of isoflavones - in the Italian population. 
These results on ovarian cancer are also in line with the litterature. The intake of isoflavones was 
associated with lower risk of ovarian cancer in a US cohort study [19], as well as in a Chinese case-
control study [75]. An inverse association between isoflavones and ovarian cancer risk can be 
explained by the observation that isoflavones have anti-estrogenic effects [5], and hence may inhibit 
the growth and proliferation of ovarian cell lines [76-78]. Another cohort study from the US 
reported a significant decrease in ovarian cancer incidence for the highest versus the lowest quintile 
of flavonol kaempferol [79], in line with these results. 
Although some flavonoids have been reported to have a favourable effect against prostate cancer 
[80], the results from epidemiological studies are inconsistent. A recent prospective study from 
Japan found that isoflavone intake was associated with a decreased risk of localized prostate cancer 
[18]. If confirmed, this finding could partly explain the lower incidence of prostate cancer in Asian 
as compared to Western populations characterized by a low consumption of isoflavone-rich foods 
as soya. In the Italian study, isoflavones derive mainly from beans, soy and soy products, the 
consumption of which is limited in Italy, and this may explain the inconsistent relation observed 
with prostate cancer. In a case-control study nested in the European Prospective Investigation into 
Cancer and Nutrition EPIC cohort study [81], higher plasma concentrations of isoflavone genistein, 
but not other isoflavones, were associated with lower risk of prostate cancer. 
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With reference to kidney cancer, a recent study showed an inverse association between the flavonol 
quercetin and renal cancer among smokers of the Alpha-Tocopherol Beta-Carotene Cancer 
Prevention (ATBC) Study cohort [82], in line with these results. 
 
8.2 TAC and cancer risk 
I obtained the estimates of dietary TEAC, TRAP and FRAP that were comparable with previous 
values showed in the literature [83]. Fruit and vegetable mainly contributes to the TEAC (42%), 
TRAP (35%) and FRAP (40%) intakes. Among the principal food sources, there were wine, citrus 
fruits, apples and pears, and bread. Given the high correlation between the three TAC assays, 
examining only one measure should be considered for the next studies. 
For colorectal cancer, we found that TEAC, TRAP and FRAP were inversely related with the risk 
of this tumor. Associations were stronger for rectal cancer. These findings are in agreement with 
those from the Health Professional Follow-up Study that found an inverse association between 
FRAP and rectal cancer (OR=0.58, 95% CI, 0.35-0.96) on a cohort of 47,399 men including 201 
rectal cancers [20].  
Adjustment for flavonoids and proanthocyanidins reduced the strength of the inverse relations 
between TAC and colorectal cancer risk. The association disappeared after adjusting for 
anthocyanidin intake. Given the high correlation between TAC and anthocyanidins, however, these 
results are difficult to be interpreted. 
Availability of TAC estimates allowed me to investigate the associations that I found between 
anthocyanidins, flavones, flavonols, and proanthocyanidins with more than 10 mers and colorectal 
cancer, further adjusted for TAC intakes. I found that ORs did not change after allowance for 
FRAP. I obtained similar OR estimates adjusting for TEAC and TRAP rather than FRAP. 
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8.3 Statistical techniques to face the problem of high collinearity among dietary factors 
FA allows to study whether there are possible patterns of flavonoids more associated to the risk of 
cancer than single flavonoids or classes of flavonoids. We found that the variance of the entire 
structure of flavonoids can be explained by five factors, and found that 3 of them were inversely 
related to colorectal cancer risk. Based on this result, it is possible to define a pattern of foods in 
order to have a more practical results, also in terms of dietary modification recommendations for 
cancer prevention using a multivariate regression model or a reduced rank regression. This would 
allow to find a cluster of foods that maximizes the variance of these factors and has a protective 
effect on the disease trough flavonoids.  
In nutritional epidemiological research, dietary patterns have substantially used over the past 
several years [84]. Patterning methods consider multiple foods, beverages, and/or nutrients and 
create dietary variables that more realistically resemble actual eating behavior, but no study have 
investigated specifically flavonoids, neither included flavonoids in the analyses. Only one study 
investigated a dietary pattern that was predictive of flavonol intake and pancreatic cancer risk in a 
German study [85]. Using data from the Multiethnic cohort, Nothlings and colleagues found a 
flavonol based food pattern, consisting mainly of tea, fruit, cabbage, and wine, that was inversely 
associated to the risk of pancreatic cancer in that population; they could not, however, replicate this 
association in the EPIC study [85]. I also identified a combination of foods from the flavonoids 
strongly related to pancreatic cancer risk. It was different from that suggested in the German study, 
but it was inversely associated to pancreatic cancer. Eating one more portion of apples, pears, 
pulses, peaches, apricots or prunes every day reduced the risk of pancreatic cancer by 25% [45]. 
The definition of dietary patterns on all complex of nutrients and dietary compounds including 
flavonoids would allow to describe in a complete manner all the variances from the diet that play a 
role in the evaluation of cancer risk. This work was started by the Department of Occupational and 
Environmental Health in 2008 [86], but did not include flavonoids up to now.  
52 
All these analysis could be applied to residuals on energy intake. I did adjust for energy intake in 
the logistic models, but in some cases the use of residuals is preferable for a more strong 
adjustment. Residuals would have allowed me to easily compare cases and controls and selected 
covariates (e.g. sex, age) by levels of flavonoid intake (and their factors) taking into account 
differences in energy intake. However, more difficulties will come up in adjusting for wine 
consumption since the residuals on energy includes also the adjustment for alcohol intake which 
contributes to the total energy intake.  
Computing the intake of flavonoids without the intake deriving by wine consumption allowed me to 
detect significant associations with oral and pharyngeal cancer that I would not have detected using 
total intake. However, this method does not allow to evaluate the effect that the total amount of 
flavonoids, taken by the diet, has on cancer risk. There is not a biological explanation for which 
flavonoids deriving by wine have not protective effect on the tumour, but is only a statistical 
problem in being able to eliminate the confounding effect of the consumption of wine on the risk. 
FA has resolved in part this problem and has allowed to make further analysis in strata. 
There are flavonoid for which their intake derives exclusively by one and only one source of food. 
For example, FLAVAN3-(-)-Epigallocatechin derives only by tea (99.0%), or FLAVA-Hesperetin 
derives only by citrus fruit (92.8%). In this case, we must consider that the flavonoid and the food 
source have a common variance and it is not possible disentangle their effects on the risk of disease.  
 
8.4 A method to take into account the over-reporting of cases in case-control studies 
It is difficult to interpret and compare the results on the residuals on fruit and vegetables and on the 
residuals on water. Of course, water can be used as energy in adjusting for a recall bias of a case-
control study design, and has not the limitation to be related to the cancer risk like fruit and 
vegetables, or energy. In fact, the use of residuals on fruit and vegetables is a strong adjustment and 
can weaken the risk estimates of flavonoids.  
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It interesting to see, however, that the residual method on TAC gave the same results of the 
residuals on water. In both analysis in fact, the relations for flavanones and flavonols persisted 
whereas the association for proanthocyanidins disappeared. These analyses provide evidence of a 
protective effect of flavanones and flavonols on oral and pharyngeal cancer.  
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9. CONCLUSION 
In conclusion, the findings this project on a large network of Italian case-control studies provide 
support for an apparent protective role of flavanones on upper aerodigestive tract cancers, flavonols, 
proanthocyanidins on stomach and pancreatic cancer, anthocyanidins and proanthocyanidins on 
colorectal cancer, flavonols and flavones on breast cancer, isoflavones on ovarian cancer, and 
flavonols on renal cancer. For most investigated neoplasms, adjustment for flavonoids reduced the 
strength of the inverse association between vegetables or fruit consumption and the risk of cancer, 
whereas allowance for fruit and vegetables consumption only moderately changed the observed 
associations with flavonoids. Misclassification may play a role, but it appears that a diet rich in fruit 
and vegetables does not alone account for the protections of flavonoids on the risk of several cancer 
sites, whereas the inverse relation of cancer with fruit and vegetables is not totally explained by 
flavonoid intake. 
With reference to TAC, the analysis on colorectal cancer found that TAC was inversely associated 
to the risk of this tumor. However, a diet rich antioxidants does not alone account for the 
protections of flavonoids on the risk of colorectal cancer. Similar analysis on other cancer sites are 
needed. 
The application of FA to the “construct of flavonoids” investigated the structure of flavonoids and 
analysed their variances. This allowed to highlight the importance to analyse individual flavonoids 
or groups of flavonoids instead of their classes, and to resolve – in part – the problem of the strong 
confounding effect of wine consumption. Moreover, these results suggest to include flavonoids and 
TAC in the estimation of dietary patterns in nutritional epidemiologic research.  
At last, the proposal to use residuals on water or fruit and vegetables leaves open an 
epidemiological question, given the criticism that the case-control studies still face in the 
epidemiological literature, but can be of any help since new statistical methods are needed to 
resolve these limitations.  
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Table 1 Primary contributors to flavonoid and proanthocyanidin intake among controls. Italy, 1991-2005. 
 
Principal flavonoid and proanthocyanidin food sources 
1 2 3 
Flavonoids 
Flavanols  Tea (50%) Apples and pears (20%) Wine (15%) 
Flavanones  Citrus fruit (88%) Fruit juice (11%)  
Flavonols  Apples and pears (16%) Fennels (16%) Mixed vegetable salad (12%) 
Anthocyanidins  Wine (46%) Strawberries and cherries (37%) Onions (7%) 
Flavones  Spinaches and Swiss chards (29%) Vegetable and bean soups (17%) Tea (15%) 
Isoflavones  Soya milk (45%) Soya (21%) Vegetable and bean soups (12%) 
Total of the above flavonoids  Citrus fruit (28%) Tea (22%) Apples and pears (11%) 
Proanthocyanidins 
Monomers Wine (54%) Apples and pears (18%) Tea (7%) 
Dimers Wine (50%) Apples and pears (26%) Peaches, apricots and prunes (7%) 
Trimers Apples and pears (47%) Wine (13%) Peaches, apricots and prunes (10%) 
4-6mers Apples and pears (45%) Wine (14%) Vegetable and bean soups (11%) 
7-10mers Apples and pears (48%) Wine (13%) Vegetable and bean soups (12%) 
> 10 mers Apples and pears (32%) Vegetable and bean soups (16%) Grape (13%) 
Total proanthocyanidins Apples and pears (35%) Wine (24%) Vegetable and bean soups (11%) 
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Figure 1 - Odds ratios and 95% confidence intervals of selected 
cancers for the highest vs the lowest levels of vegetable 
consumption. Italy, 1991-2005. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*
 Raw vegetables 
0.0 1.0 2.0
Oral cavity/pharynx*
Esophagus*
Stomach   
Colorectum   
Liver   
Larynx   
Breast*
Endometrium   
Ovary*
Prostate*
Kidney  
Non-Hodgkin's lymphomas  
0.5 1.5
63 
 
Figure 2 - Odds ratios and 95% confidence intervals of selected 
cancers for the highest vs the lowest levels of fruit consumption. 
Italy, 1991-2005 
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APPENDIXES
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APPENDIX 1 – Chapter 4 
Table 1 (Appendix 1) – Multiple logistic regression-derived odds ratios (ORs)a and corresponding 95% 
confidence intervals (CIs) according to intake quintiles of six classes of flavonoids, as well as total 
flavonoids, among 250 hepatitis B and/or C virus positive hepatocellular carcinoma (HCC) cases, 83 
hepatitis B and C virus negative HCC cases, and 6 cholangiocarcinoma cases. Greece, 1995-1998. 
Flavonoids 
Quintiles of intake
b 
2 trend 
(p value) 1
c
 2 3 4 5 
Flavanones 
Upper cutpoint (mg/day) 57.0 103.2 109.1 120.6 -  
HCC Virus Positive cases 42 37 50 54 67 1.38 (0.24) 
OR
 
1 0.78 1.10 1.11 1.21  
(95% CI)  (0.43-1.39) (0.63-1.93) (0.63-1.94) (0.69-2.11)  
HCC Virus Negative cases 26 11 9 8 29 0.05 (0.82) 
OR 1 0.57 0.42 0.34 1.18  
(95% CI)  (0.24-1.32) (0.17-1.03) (0.13-0.85) (0.56-2.47)  
Cholangiocarcinoma cases
d
 2 1 1 1 1 0.46 (0.50) 
Controls 72 72 72 72 72  
Flavan-3-ols 
Upper cutpoint (mg/day) 25.3 40.2 51.0 66.3 -  
HCC Virus Positive cases 35 56 39 59 61 0.16 (0.69) 
OR
 
1 1.25 0.87 1.23 1.17  
(95% CI)  (0.70-2.24) (0.47-1.59) (0.69-2.19) (0.65-2.12)  
HCC Virus Negative cases 18 17 14 14 20 0.03 (0.87) 
OR 1 1.12 0.87 0.94 1.14  
(95% CI)  (0.48-2.58) (0.37-2.06) (0.40-2.25) (0.50-2.58)  
Cholangiocarcinoma cases
d
 3 2 1 0 0 3.38 (0.066) 
Controls 72 72 72 72 72  
Flavonols 
Upper cutpoint (mg/day) 21.6 28.3 32.5 37.3 -  
HCC Virus Positive cases 33 54 46 56 61 0.18 (0.67) 
OR
 
1 1.75 1.21 1.41 1.35  
(95% CI)  (0.98-3.12) (0.66-2.21) (0.78-2.53) (0.75-2.44)  
HCC Virus Negative cases 20 17 13 12 21 0.02 (0.89) 
OR 1 0.82 0.58 0.63 1.11  
(95% CI)  (0.37-1.81) (0.25-1.37) (0.27-1.51) (0.51-2.43)  
Cholangiocarcinoma cases
d
 1 4 0 1 0 1.80 (0.18) 
Controls 72 72 72 72 72  
Anthocyanidins 
Upper cutpoint (mg/day) 10.2 40.7 64.6 152.7 -  
HCC Virus Positive cases 35 70 33 41 71 0.16 (0.68) 
OR
 
1 1.31 0.97 0.76 1.42  
(95% CI)  (0.77-2.25) (0.51-1.85) (0.41-1.41) (0.81-2.47)  
HCC Virus Negative cases 13 24 9 15 22 0.49 (0.48) 
OR 1 1.82 0.97 1.19 1.73  
(95% CI)  (0.81-4.09) (0.33-2.81) (0.47-3.00) (0.74-4.04)  
Cholangiocarcinoma cases
d
 3 2 1 0 0 3.64 (0.056) 
Controls 72 93 51 66 78  
2 
 
Quintiles of intake
b 
2 trend 
(p value) 1
b
 2 3 4 5 
Flavones 
Upper cutpoint (mg/day) 0.25 0.58 0.90 1.16 -  
HCC Virus Positive cases 44 49 54 64 40 3.87 (0.049) 
OR 1 0.85 0.84 0.84 0.50  
(95% CI)  (0.48-1.51) (0.46-1.51) (0.47-1.52) (0.27-0.94)  
HCC Virus Negative cases 19 22 12 20 10 2.99 (0.084) 
OR 1 1.03 0.52 0.91 0.41  
(95% CI)  (0.48-2.19) (0.21-1.26) (0.40-2.08) (0.16-1.06)  
Cholangiocarcinoma cases
d
 0 2 0 1 3 1.41 (0.24) 
Controls 72 72 71 71 74  
Isoflavones 
Upper cutpoint (mg/day) 0.03 0.04 0.07 0.32 -  
HCC Virus Positive cases 38 42 49 54 67 1.36 (0.24) 
OR
 
1 0.96 0.97 0.83 0.74  
(95% CI)  (0.55-1.67) (0.53-1.47) (0.48-1.46) (0.41-1.32)  
HCC Virus Negative cases 20 13 12 19 19 0.02 (0.88) 
OR 1 0.53 0.47 0.88 0.85  
(95% CI)  (0.22-1.24) (0.19-1.17) (0.41-1.89) (0.39-1.86)  
Cholangiocarcinoma cases
d
 3 1 0 1 1 1.51 (0.22)
 
Controls 72 72 72 72 72  
Total flavonoids 
Upper cutpoint (mg/day) 145.8 212.6 256.8 358.1 -  
HCC Virus Positive cases 38 42 47 56 67 0.68 (0.41) 
OR
 
1 0.93 0.91 0.98 1.22  
(95% CI)  (0.52-1.66) (0.51-1.65) (0.54-1.77) (0.69-2.16)  
HCC Virus Negative cases 22 14 6 19 22 0.09 (0.76) 
OR 1 0.74 0.28 0.81 0.96  
(95% CI)  (0.33-1.70) (0.10-0.82) (0.35-1.84) (0.43-2.12)  
Cholangiocarcinoma cases
d
 3 1 2 0 0 3.61 (0.057) 
Controls 72 72 72 72 72  
a
Adjusted for gender, age, education, tobacco smoking, and total energy intake. 
b
Control generated 
quintiles
 c
Reference category. 
d
Adjusted only for gender; quintile specific odds ratios not calculated 
because of sparsity of data. 
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Figure 1 (Appendix 1) - Odds ratios and 95% confidence intervals of cancers at the 
upper aerodigestive tract for the highest versus the lowest quintile of intake of selected 
classes of flavonoids. Italy, 1992-2005.  
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Figure 2 (Appendix 1) - Odds ratios and 95% confidence intervals of stomach 
cancer for the highest versus the lowest quintile of intake of six classes of 
flavonoids and two classes of proanthocyanidins. Italy, 1997-2007. 
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Figure 3 (Appendix 1) - Odds ratios and 95% confidence intervals of colorectal cancer 
for the highest versus the lowest quintile of intake of selected classes of flavonoids and 
proanthocyanidins. Italy, 1992-1996. 
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Figure 4 (Appendix 1) - Odds ratios and 95% confidence intervals of pancreatic 
cancer for the highest versus the lowest quintile of intake of selected classes of 
flavonoids and proanthocyanidins. Italy, 1991-2008. 
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Figure 5 (Appendix 1) - Odds ratios and 95% confidence intervals of breast, ovary, and 
kidney cancers for the highest versus the lowest quintile of intake of selected classes of 
flavonoids. Italy, 1991-2004. 
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APPENDIX 2 – Chapter 5 
 
Table 1 (Appendix 2) - Distribution of 1,953 cases with colorectal cancer and 4,154 
controls according to quintiles of energy-adjusted classes of TAC among controls. (Italy, 
1992-1996) 
 Mean
 
(SD)
a
  Quintiles of intake
b
 
   1 2 3 4 5 
TAC        
TEAC (mmol/d) 4.47 (2.55)       
     Upper cutoff point   3.17 3.93 4.59 5.54 - 
     Cases   389 397 362 389 416 
TRAP (mmol/d) 4.56 (3.09)       
     Upper cutoff point   2.88 3.78 4.61 5.94 - 
     Cases   398 364 376 392 423 
FRAP (mmol/d) 11.45 (6.65)       
     Upper cutoff point   7.93 9.93 11.75 14.34 - 
     Cases   393 375 379 384 422 
a
 Mean intake and standard deviation (SD) among control distribution. 
b 
Based on the control distribution. Number of controls across quintiles could slightly differ 
between 828 and 831 according to the distributions of each measure of TAC. 
2 
Table 2 (Appendix 2) - Correlation of TEAC, TRAP and 
FRAP with selected covariates among 4,154 controls. (Italy, 
1992-1996) 
 TEAC TRAP FRAP 
Fruit 0.29 0.19 0.27 
Vegetables 0.24 0.16 0.21 
Flavonoids 0.64 0.56 0.65 
Anthocyanidins 0.86 0.89 0.86 
Flavones 0.04 -0.02 0.05 
Flavonols 0.30 0.27 0.30 
Proanthocyanidins 0.62 0.59 0.59 
Polymers ≥ 10 mers 0.35 0.30 0.32 
Vitamin C 0.35 0.21 0.33 
Carotene 0.21 0.13 0.19 
Vitamin E 0.39 0.25 0.32 
Vitamin D 0.17 0.10 0.14 
Beta carotene 0.23 0.14 0.20 
Energy 0.63 0.53 0.59 
 
3 
 
 
a 
Estimated using multiple logistic regression models adjusted for sex, age, study centre, family history, education, alcohol consumption, body mass 
index, physical activity and energy intake, according to the residual model. 
b 
Based on the control distribution. 
c
 Reference category. 
d 
Estimated for 
an increment of intake equal to the difference between the upper cut-off points of the 4
th
 and the 1
st
 quintiles. 
 
 
Table 3 (Appendix 2) - Odds ratios (ORs)
 a
 of colorectal cancer among 1,953 cases with colorectal cancer and 4,154 controls, and corresponding 
95% confidence intervals (CIs) according to quintiles
b
 (I-V) of three energy-adjusted total antioxidant capacity indexes. (Italy, 1992-1996) 
 
OR (95% CI) 
2 
trend 
(p-
value) 
 
Quintiles 
b
 
OR continuous 
 d
 
  I
c
 II III IV V    
TEAC - 0.95 (0.79-1.13) 0.78 (0.65-0.94) 0.77 (0.64-0.93) 0.78 (0.63-0.96) 0.002 0.89 (0.82-0.97) 
TRAP - 0.83 (0.70-1.00) 0.77 (0.64-0.92) 0.70 (0.58-0.85) 0.74 (0.60-0.92) 0.001 0.90 (0.83-0.98) 
FRAP - 0.87 (0.73-1.05) 0.79 (0.66-0.95) 0.74 (0.62-0.90) 0.78 (0.63-0.96) 0.003 0.89 (0.82-0.98) 
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Table 1 (Appendix 3) - Distribution of 34 flavonoids in 1953 cases and 4,154 controls from the 
study on colorectal cancer. Italy, 1992-1996. 
Variables Median St dev Minimum Maximum 
FL1 
FL2 
FL3 
FL4 
FL5 
FL6 
FL7 
FL8 
FL9 
FL10 
FL11 
FL12 
FL13 
FL14 
FL15 
FL16 
FL17 
FL18 
FL19 
FL20 
FL21 
FL22 
FL23 
FL24 
FL25 
FL26 
FL27 
FL28 
FL29 
FL30 
FL31 
FL32 
FL33 
FL34 
ISO-DAIDZEINA 
ISO-GENISTEIN 
ANTHO-Cyanidin 
ANTHO-Delphinidin 
ANTHO-Malvidin 
ANTHO-Pelargonidin 
ANTHO-Peonidin 
ANTHO-Petunidin 
FLAVAN3-(+)-Catechin 
FLAVAN3-(-)-Epigallocatechin 
FLAVAN3-(-)-Epicatechin 
FLAVAN3-(-)-Epicatechin 3-gallate 
FLAVAN3-(-)-Epigallocatechin 3-gallate 
FLAVAN3-Theaflavin 
FLAVAN3-Thearubigins 
FLAVA-Eriodictyol 
FLAVA-Hesperetin 
FLAVA-naringenin 
FLAVONE-Apigenin 
FLAVONE-Luteolin 
FLAVONO-Isorhamnetin 
FLAVONO-Kaempferol 
FLAVONO-Myricetin 
FLAVONO-Quercetin 
FLAVAN3-Theaflavin-3,3'-digallate 
FLAVAN3-Theaflavin-3'-gallate 
FLAVAN3-Theaflavin-3-gallate 
FLAVAN3-(+)-Gallocatechin 
Proanthocyanidin-Monomers 
Proanthocyanidin-Dimers 
Proanthocyanidin-Trimers 
Proanthocyanidin-4-6mers 
Proanthocyanidin-7-10mers 
Proanthocyanidin-Polymers 
30.34 
33.00 
6.83 
1.00 
8.38 
0.03 
1.91 
2.04 
17.38 
2.96 
20.45 
2.46 
6.81 
0.10 
8.48 
0.07 
24.35 
13.71 
0.23 
0.25 
1.47 
1.65 
2.39 
15.99 
0.11 
0.08 
0.09 
0.47 
44.68 
57.74 
19.64 
67.04 
53.82 
115.93 
221.74 
301.05 
6.65 
1.30 
10.90 
0.05 
2.23 
2.65 
15.64 
6.30 
12.42 
4.29 
14.52 
0.22 
18.08 
0.12 
20.90 
12.37 
0.14 
0.19 
1.29 
1.07 
2.31 
7.27 
0.23 
0.18 
0.18 
1.00 
35.16 
42.60 
11.46 
36.36 
28.93 
60.02 
0.00 
0.21 
0.01 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.00 
0.05 
0.01 
1.07 
0.00 
0.00 
0.00 
0.00 
0.04 
0.00 
0.00 
0.00 
0.00 
0.00 
10037.06 
13663.07 
117.15 
17.14 
144.05 
1.03 
29.49 
35.03 
205.57 
106.92 
147.25 
72.22 
246.38 
3.78 
306.72 
1.78 
230.85 
178.86 
1.68 
2.69 
19.48 
15.65 
39.37 
109.12 
3.92 
2.97 
3.11 
17.01 
430.27 
522.53 
157.57 
459.57 
387.76 
675.39 
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Table 2 (Appendix 3) - Pearson correlation coefficients and Prob>|r| with H0: Rho=0 among 34 flavonoids in 1953 
cases and 4,154 controls from the study on colorectal cancer. Italy, 1992-1996. 
 FL1 FL2 FL3 FL4 FL5 FL6 FL7 FL8 FL9 
FL1 
ISO-DAIDZEINA 
1.00000 
 
0.99821 
<.0001 
0.00987 
0.4407 
-0.01774 
0.1657 
-0.01774 
0.1657 
0.01004 
0.4328 
-0.01636 
0.2013 
-0.01774 
0.1657 
-0.01380 
0.2811 
FL2 
ISO-GENISTEIN 
0.99821 
<.0001 
1.00000 
 
0.01053 
0.4108 
-0.01404 
0.2727 
-0.01404 
0.2728 
0.00946 
0.4597 
-0.01273 
0.3199 
-0.01404 
0.2728 
-0.01449 
0.2575 
FL3 
ANTHO-Cyanidin 
0.00987 
0.4407 
0.01053 
0.4108 
1.00000 
 
0.04896 
0.0001 
0.04892 
0.0001 
0.92414 
<.0001 
0.17070 
<.0001 
0.04889 
0.0001 
0.12474 
<.0001 
FL4 
ANTHO-Delphinidin 
-0.01774 
0.1657 
-0.01404 
0.2727 
0.04896 
0.0001 
1.00000 
 
1.00000 
<.0001 
-0.05597 
<.0001 
0.99179 
<.0001 
1.00000 
<.0001 
0.97494 
<.0001 
FL5 
ANTHO-Malvidin 
-0.01774 
0.1657 
-0.01404 
0.2728 
0.04892 
0.0001 
1.00000 
<.0001 
1.00000 
 
-0.05624 
<.0001 
0.99178 
<.0001 
1.00000 
<.0001 
0.97495 
<.0001 
FL6 
ANTHO-Pelargonidin 
0.01004 
0.4328 
0.00946 
0.4597 
0.92414 
<.0001 
-0.05597 
<.0001 
-0.05624 
<.0001 
1.00000 
 
0.06733 
<.0001 
-0.05636 
<.0001 
0.01658 
0.1951 
FL7 
ANTHO-Peonidin 
-0.01636 
0.2013 
-0.01273 
0.3199 
0.17070 
<.0001 
0.99179 
<.0001 
0.99178 
<.0001 
0.06733 
<.0001 
1.00000 
 
0.99178 
<.0001 
0.97643 
<.0001 
FL8 
ANTHO-Petunidin 
-0.01774 
0.1657 
-0.01404 
0.2728 
0.04889 
0.0001 
1.00000 
<.0001 
1.00000 
<.0001 
-0.05636 
<.0001 
0.99178 
<.0001 
1.00000 
 
0.97494 
<.0001 
FL9 
FLAVAN3-(+)-Catechin 
-0.01380 
0.2811 
-0.01449 
0.2575 
0.12474 
<.0001 
0.97494 
<.0001 
0.97495 
<.0001 
0.01658 
0.1951 
0.97643 
<.0001 
0.97494 
<.0001 
1.00000 
 
FL10 
FLAVAN3-(-)-Epigallocatechin 
-0.00846 
0.5084 
-0.00859 
0.5024 
-0.00547 
0.6691 
-0.02112 
0.0989 
-0.02110 
0.0993 
-0.01077 
0.4000 
-0.02226 
0.0819 
-0.02111 
0.0990 
0.09507 
<.0001 
FL11 
FLAVAN3-(-)-Epicatechin 
0.02416 
0.0590 
-0.00998 
0.4355 
0.17431 
<.0001 
0.66830 
<.0001 
0.66831 
<.0001 
0.08882 
<.0001 
0.67962 
<.0001 
0.66829 
<.0001 
0.77095 
<.0001 
FL12 
FLAVAN3-(-)-Epicatechin 3-gallate 
-0.00808 
0.5279 
-0.00845 
0.5091 
0.02761 
0.0310 
-0.02191 
0.0868 
-0.02189 
0.0872 
0.01985 
0.1210 
-0.01900 
0.1377 
-0.02190 
0.0870 
0.11224 
<.0001 
FL13 
FLAVAN3-(-)-Epigallocatechin 3-gallate 
-0.00846 
0.5084 
-0.00859 
0.5023 
-0.00548 
0.6686 
-0.02112 
0.0988 
-0.02110 
0.0992 
-0.01078 
0.3996 
-0.02227 
0.0819 
-0.02111 
0.0990 
0.09506 
<.0001 
FL14 
FLAVAN3-Theaflavin 
-0.00846 
0.5084 
-0.00859 
0.5023 
-0.00548 
0.6686 
-0.02112 
0.0988 
-0.02110 
0.0992 
-0.01078 
0.3996 
-0.02227 
0.0819 
-0.02111 
0.0990 
0.09506 
<.0001 
FL15 
FLAVAN3-Thearubigins 
-0.00846 
0.5084 
-0.00859 
0.5023 
-0.00548 
0.6686 
-0.02112 
0.0988 
-0.02110 
0.0992 
-0.01078 
0.3996 
-0.02227 
0.0819 
-0.02111 
0.0990 
0.09506 
<.0001 
FL16 
FLAVA-Eriodictyol 
0.02998 
0.0191 
0.02994 
0.0193 
0.11961 
<.0001 
-0.05453 
<.0001 
-0.05452 
<.0001 
0.10726 
<.0001 
-0.04032 
0.0016 
-0.05454 
<.0001 
-0.01297 
0.3107 
FL17 
FLAVA-Hesperetin 
-0.00028 
0.9828 
-0.00631 
0.6223 
0.21014 
<.0001 
-0.06289 
<.0001 
-0.06289 
<.0001 
0.20325 
<.0001 
-0.03615 
0.0047 
-0.06291 
<.0001 
0.02238 
0.0803 
FL18 
FLAVA-naringenin 
0.01093 
0.3933 
0.00583 
0.6489 
0.19985 
<.0001 
-0.07837 
<.0001 
-0.07837 
<.0001 
0.19021 
<.0001 
-0.05326 
<.0001 
-0.07839 
<.0001 
-0.00271 
0.8325 
FL19 
FLAVONE-Apigenin 
-0.00661 
0.6056 
-0.00194 
0.8797 
0.16096 
<.0001 
0.10143 
<.0001 
0.10146 
<.0001 
0.05472 
<.0001 
0.10896 
<.0001 
0.10144 
<.0001 
0.18733 
<.0001 
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FL20 
FLAVONE-Luteolin 
0.00087 
0.9459 
-0.00040 
0.9749 
0.12492 
<.0001 
0.00059 
0.9633 
0.00061 
0.9619 
0.08293 
<.0001 
0.01134 
0.3758 
0.00058 
0.9641 
0.07687 
<.0001 
FL21 
FLAVONO-Isorhamnetin 
0.00730 
0.5685 
0.00857 
0.5030 
0.31243 
<.0001 
0.09379 
<.0001 
0.09379 
<.0001 
0.08206 
<.0001 
0.10429 
<.0001 
0.09377 
<.0001 
0.12383 
<.0001 
FL22 
FLAVONO-Kaempferol 
0.00600 
0.6394 
0.00421 
0.7425 
0.16465 
<.0001 
0.11305 
<.0001 
0.11308 
<.0001 
0.08925 
<.0001 
0.12486 
<.0001 
0.11305 
<.0001 
0.21774 
<.0001 
FL23 
FLAVONO-Myricetin 
-0.00650 
0.6114 
-0.00557 
0.6632 
0.08360 
<.0001 
0.60236 
<.0001 
0.60238 
<.0001 
0.00971 
0.4483 
0.60330 
<.0001 
0.60236 
<.0001 
0.63963 
<.0001 
FL24 
FLAVONO-Quercetin 
0.02933 
0.0219 
0.00847 
0.5082 
0.26715 
<.0001 
0.26833 
<.0001 
0.26834 
<.0001 
0.12738 
<.0001 
0.28493 
<.0001 
0.26832 
<.0001 
0.37464 
<.0001 
FL25 
FLAVAN3-Theaflavin-3,3'-digallate 
-0.00846 
0.5084 
-0.00859 
0.5023 
-0.00548 
0.6686 
-0.02112 
0.0988 
-0.02110 
0.0992 
-0.01078 
0.3996 
-0.02227 
0.0819 
-0.02111 
0.0990 
0.09506 
<.0001 
FL26 
FLAVAN3-Theaflavin-3'-gallate 
-0.00846 
0.5084 
-0.00859 
0.5023 
-0.00548 
0.6686 
-0.02112 
0.0988 
-0.02110 
0.0992 
-0.01078 
0.3996 
-0.02227 
0.0819 
-0.02111 
0.0990 
0.09506 
<.0001 
FL27 
FLAVAN3-Theaflavin-3-gallate 
-0.00846 
0.5084 
-0.00859 
0.5023 
-0.00548 
0.6686 
-0.02112 
0.0988 
-0.02110 
0.0992 
-0.01078 
0.3996 
-0.02227 
0.0819 
-0.02111 
0.0990 
0.09506 
<.0001 
FL28 
FLAVAN3-(+)-Gallocatechin 
-0.00846 
0.5084 
-0.00859 
0.5023 
-0.00548 
0.6686 
-0.02112 
0.0988 
-0.02110 
0.0992 
-0.01078 
0.3996 
-0.02227 
0.0819 
-0.02111 
0.0990 
0.09506 
<.0001 
FL29 
Proanthocyanidin-Monomers 
-0.00530 
0.6785 
-0.01185 
0.3546 
0.12265 
<.0001 
0.90762 
<.0001 
0.90763 
<.0001 
0.01652 
0.1968 
0.90909 
<.0001 
0.90762 
<.0001 
0.94713 
<.0001 
FL30 
Proanthocyanidin-Dimers 
0.00155 
0.9035 
-0.01073 
0.4019 
0.13388 
<.0001 
0.90819 
<.0001 
0.90819 
<.0001 
0.02627 
0.0401 
0.91092 
<.0001 
0.90818 
<.0001 
0.94521 
<.0001 
FL31 
Proanthocyanidin-Trimers 
0.04046 
0.0016 
0.00516 
0.6871 
0.23331 
<.0001 
0.26243 
<.0001 
0.26244 
<.0001 
0.17204 
<.0001 
0.28491 
<.0001 
0.26241 
<.0001 
0.37760 
<.0001 
FL32 
Proanthocyanidin-4-6mers 
0.04170 
0.0011 
0.00594 
0.6428 
0.26208 
<.0001 
0.31610 
<.0001 
0.31612 
<.0001 
0.18929 
<.0001 
0.34091 
<.0001 
0.31609 
<.0001 
0.43394 
<.0001 
FL33 
Proanthocyanidin-7-10mers 
0.04539 
0.0004 
0.00701 
0.5838 
0.25419 
<.0001 
0.29333 
<.0001 
0.29334 
<.0001 
0.17983 
<.0001 
0.31698 
<.0001 
0.29332 
<.0001 
0.41364 
<.0001 
FL34 
Proanthocyanidin-Polymers 
0.03587 
0.0051 
0.01013 
0.4286 
0.33152 
<.0001 
0.32649 
<.0001 
0.32651 
<.0001 
0.24344 
<.0001 
0.35854 
<.0001 
0.32648 
<.0001 
0.45822 
<.0001 
 
 
 FL10 FL11 FL12 FL13 FL14 FL15 FL16 FL17 FL18 
FL1 
ISO-DAIDZEINA 
-0.00846 
0.5084 
0.02416 
0.0590 
-0.00808 
0.5279 
-0.00846 
0.5084 
-0.00846 
0.5084 
-0.00846 
0.5084 
0.02998 
0.0191 
-0.00028 
0.9828 
0.01093 
0.3933 
FL2 
ISO-GENISTEIN 
-0.00859 
0.5024 
-0.00998 
0.4355 
-0.00845 
0.5091 
-0.00859 
0.5023 
-0.00859 
0.5023 
-0.00859 
0.5023 
0.02994 
0.0193 
-0.00631 
0.6223 
0.00583 
0.6489 
FL3 
ANTHO-Cyanidin 
-0.00547 
0.6691 
0.17431 
<.0001 
0.02761 
0.0310 
-0.00548 
0.6686 
-0.00548 
0.6686 
-0.00548 
0.6686 
0.11961 
<.0001 
0.21014 
<.0001 
0.19985 
<.0001 
FL4 
ANTHO-Delphinidin 
-0.02112 
0.0989 
0.66830 
<.0001 
-0.02191 
0.0868 
-0.02112 
0.0988 
-0.02112 
0.0988 
-0.02112 
0.0988 
-0.05453 
<.0001 
-0.06289 
<.0001 
-0.07837 
<.0001 
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FL5 
ANTHO-Malvidin 
-0.02110 
0.0993 
0.66831 
<.0001 
-0.02189 
0.0872 
-0.02110 
0.0992 
-0.02110 
0.0992 
-0.02110 
0.0992 
-0.05452 
<.0001 
-0.06289 
<.0001 
-0.07837 
<.0001 
FL6 
ANTHO-Pelargonidin 
-0.01077 
0.4000 
0.08882 
<.0001 
0.01985 
0.1210 
-0.01078 
0.3996 
-0.01078 
0.3996 
-0.01078 
0.3996 
0.10726 
<.0001 
0.20325 
<.0001 
0.19021 
<.0001 
FL7 
ANTHO-Peonidin 
-0.02226 
0.0819 
0.67962 
<.0001 
-0.01900 
0.1377 
-0.02227 
0.0819 
-0.02227 
0.0819 
-0.02227 
0.0819 
-0.04032 
0.0016 
-0.03615 
0.0047 
-0.05326 
<.0001 
FL8 
ANTHO-Petunidin 
-0.02111 
0.0990 
0.66829 
<.0001 
-0.02190 
0.0870 
-0.02111 
0.0990 
-0.02111 
0.0990 
-0.02111 
0.0990 
-0.05454 
<.0001 
-0.06291 
<.0001 
-0.07839 
<.0001 
FL9 
FLAVAN3-(+)-Catechin 
0.09507 
<.0001 
0.77095 
<.0001 
0.11224 
<.0001 
0.09506 
<.0001 
0.09506 
<.0001 
0.09506 
<.0001 
-0.01297 
0.3107 
0.02238 
0.0803 
-0.00271 
0.8325 
FL10 
FLAVAN3-(-)-Epigallocatechin 
1.00000 
 
0.22078 
<.0001 
0.99212 
<.0001 
1.00000 
<.0001 
1.00000 
<.0001 
1.00000 
<.0001 
0.09961 
<.0001 
0.01517 
0.2360 
0.01932 
0.1312 
FL11 
FLAVAN3-(-)-Epicatechin 
0.22078 
<.0001 
1.00000 
 
0.24365 
<.0001 
0.22076 
<.0001 
0.22076 
<.0001 
0.22076 
<.0001 
0.05629 
<.0001 
0.12828 
<.0001 
0.10041 
<.0001 
FL12 
FLAVAN3-(-)-Epicatechin 3-gallate 
0.99212 
<.0001 
0.24365 
<.0001 
1.00000 
 
0.99212 
<.0001 
0.99212 
<.0001 
0.99212 
<.0001 
0.11019 
<.0001 
0.04705 
0.0002 
0.04721 
0.0002 
FL13 
FLAVAN3-(-)-Epigallocatechin 3-gallate 
1.00000 
<.0001 
0.22076 
<.0001 
0.99212 
<.0001 
1.00000 
 
1.00000 
<.0001 
1.00000 
<.0001 
0.09964 
<.0001 
0.01519 
0.2354 
0.01934 
0.1307 
FL14 
FLAVAN3-Theaflavin 
1.00000 
<.0001 
0.22076 
<.0001 
0.99212 
<.0001 
1.00000 
<.0001 
1.00000 
 
1.00000 
<.0001 
0.09964 
<.0001 
0.01519 
0.2354 
0.01934 
0.1307 
FL15 
FLAVAN3-Thearubigins 
1.00000 
<.0001 
0.22076 
<.0001 
0.99212 
<.0001 
1.00000 
<.0001 
1.00000 
<.0001 
1.00000 
 
0.09964 
<.0001 
0.01519 
0.2354 
0.01934 
0.1307 
FL16 
FLAVA-Eriodictyol 
0.09961 
<.0001 
0.05629 
<.0001 
0.11019 
<.0001 
0.09964 
<.0001 
0.09964 
<.0001 
0.09964 
<.0001 
1.00000 
 
0.15487 
<.0001 
0.46482 
<.0001 
FL17 
FLAVA-Hesperetin 
0.01517 
0.2360 
0.12828 
<.0001 
0.04705 
0.0002 
0.01519 
0.2354 
0.01519 
0.2354 
0.01519 
0.2354 
0.15487 
<.0001 
1.00000 
 
0.86545 
<.0001 
FL18 
FLAVA-naringenin 
0.01932 
0.1312 
0.10041 
<.0001 
0.04721 
0.0002 
0.01934 
0.1307 
0.01934 
0.1307 
0.01934 
0.1307 
0.46482 
<.0001 
0.86545 
<.0001 
1.00000 
 
FL19 
FLAVONE-Apigenin 
0.52752 
<.0001 
0.25554 
<.0001 
0.53620 
<.0001 
0.52753 
<.0001 
0.52753 
<.0001 
0.52753 
<.0001 
0.08416 
<.0001 
0.05154 
<.0001 
0.04952 
0.0001 
FL20 
FLAVONE-Luteolin 
0.39969 
<.0001 
0.19456 
<.0001 
0.40653 
<.0001 
0.39969 
<.0001 
0.39969 
<.0001 
0.39969 
<.0001 
0.12548 
<.0001 
0.08212 
<.0001 
0.09818 
<.0001 
FL21 
FLAVONO-Isorhamnetin 
0.03826 
0.0028 
0.15271 
<.0001 
0.04772 
0.0002 
0.03827 
0.0028 
0.03827 
0.0028 
0.03827 
0.0028 
0.10907 
<.0001 
0.08451 
<.0001 
0.10435 
<.0001 
FL22 
FLAVONO-Kaempferol 
0.67437 
<.0001 
0.33159 
<.0001 
0.67674 
<.0001 
0.67439 
<.0001 
0.67439 
<.0001 
0.67439 
<.0001 
0.14987 
<.0001 
0.10464 
<.0001 
0.11373 
<.0001 
FL23 
FLAVONO-Myricetin 
0.25781 
<.0001 
0.52070 
<.0001 
0.26414 
<.0001 
0.25782 
<.0001 
0.25782 
<.0001 
0.25782 
<.0001 
0.07607 
<.0001 
0.03259 
0.0109 
0.03629 
0.0046 
FL24 
FLAVONO-Quercetin 
0.22408 
<.0001 
0.62275 
<.0001 
0.25099 
<.0001 
0.22408 
<.0001 
0.22408 
<.0001 
0.22408 
<.0001 
0.13680 
<.0001 
0.17754 
<.0001 
0.17158 
<.0001 
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FL25 
FLAVAN3-Theaflavin-3,3'-digallate 
1.00000 
<.0001 
0.22076 
<.0001 
0.99212 
<.0001 
1.00000 
<.0001 
1.00000 
<.0001 
1.00000 
<.0001 
0.09964 
<.0001 
0.01519 
0.2354 
0.01934 
0.1307 
FL26 
FLAVAN3-Theaflavin-3'-gallate 
1.00000 
<.0001 
0.22076 
<.0001 
0.99212 
<.0001 
1.00000 
<.0001 
1.00000 
<.0001 
1.00000 
<.0001 
0.09964 
<.0001 
0.01519 
0.2354 
0.01934 
0.1307 
FL27 
FLAVAN3-Theaflavin-3-gallate 
1.00000 
<.0001 
0.22076 
<.0001 
0.99212 
<.0001 
1.00000 
<.0001 
1.00000 
<.0001 
1.00000 
<.0001 
0.09964 
<.0001 
0.01519 
0.2354 
0.01934 
0.1307 
FL28 
FLAVAN3-(+)-Gallocatechin 
1.00000 
<.0001 
0.22076 
<.0001 
0.99212 
<.0001 
1.00000 
<.0001 
1.00000 
<.0001 
1.00000 
<.0001 
0.09964 
<.0001 
0.01519 
0.2354 
0.01934 
0.1307 
FL29 
Proanthocyanidin-Monomers 
0.20714 
<.0001 
0.82386 
<.0001 
0.21362 
<.0001 
0.20713 
<.0001 
0.20713 
<.0001 
0.20713 
<.0001 
0.02357 
0.0655 
0.02909 
0.0230 
0.00788 
0.5379 
FL30 
Proanthocyanidin-Dimers 
0.07198 
<.0001 
0.86773 
<.0001 
0.08209 
<.0001 
0.07197 
<.0001 
0.07197 
<.0001 
0.07197 
<.0001 
0.01686 
0.1876 
0.05317 
<.0001 
0.02833 
0.0268 
FL31 
Proanthocyanidin-Trimers 
0.07363 
<.0001 
0.75550 
<.0001 
0.09984 
<.0001 
0.07362 
<.0001 
0.07362 
<.0001 
0.07362 
<.0001 
0.12882 
<.0001 
0.21864 
<.0001 
0.19303 
<.0001 
FL32 
Proanthocyanidin-4-6mers 
0.04757 
0.0002 
0.80366 
<.0001 
0.07771 
<.0001 
0.04756 
0.0002 
0.04756 
0.0002 
0.04756 
0.0002 
0.12387 
<.0001 
0.22661 
<.0001 
0.19938 
<.0001 
FL33 
Proanthocyanidin-7-10mers 
0.04836 
0.0002 
0.81520 
<.0001 
0.08022 
<.0001 
0.04835 
0.0002 
0.04835 
0.0002 
0.04835 
0.0002 
0.11527 
<.0001 
0.21463 
<.0001 
0.18937 
<.0001 
FL34 
Proanthocyanidin-Polymers 
0.04109 
0.0013 
0.73313 
<.0001 
0.09713 
<.0001 
0.04108 
0.0013 
0.04108 
0.0013 
0.04108 
0.0013 
0.13077 
<.0001 
0.24003 
<.0001 
0.21176 
<.0001 
 
 
 FL19 FL20 FL21 FL22 FL23 FL24 FL25 FL26 FL27 
FL1 
ISO-DAIDZEINA 
-0.00661 
0.6056 
0.00087 
0.9459 
0.00730 
0.5685 
0.00600 
0.6394 
-0.00650 
0.6114 
0.02933 
0.0219 
-0.00846 
0.5084 
-0.00846 
0.5084 
-0.00846 
0.5084 
FL2 
ISO-GENISTEIN 
-0.00194 
0.8797 
-0.00040 
0.9749 
0.00857 
0.5030 
0.00421 
0.7425 
-0.00557 
0.6632 
0.00847 
0.5082 
-0.00859 
0.5023 
-0.00859 
0.5023 
-0.00859 
0.5023 
FL3 
ANTHO-Cyanidin 
0.16096 
<.0001 
0.12492 
<.0001 
0.31243 
<.0001 
0.16465 
<.0001 
0.08360 
<.0001 
0.26715 
<.0001 
-0.00548 
0.6686 
-0.00548 
0.6686 
-0.00548 
0.6686 
FL4 
ANTHO-Delphinidin 
0.10143 
<.0001 
0.00059 
0.9633 
0.09379 
<.0001 
0.11305 
<.0001 
0.60236 
<.0001 
0.26833 
<.0001 
-0.02112 
0.0988 
-0.02112 
0.0988 
-0.02112 
0.0988 
FL5 
ANTHO-Malvidin 
0.10146 
<.0001 
0.00061 
0.9619 
0.09379 
<.0001 
0.11308 
<.0001 
0.60238 
<.0001 
0.26834 
<.0001 
-0.02110 
0.0992 
-0.02110 
0.0992 
-0.02110 
0.0992 
FL6 
ANTHO-Pelargonidin 
0.05472 
<.0001 
0.08293 
<.0001 
0.08206 
<.0001 
0.08925 
<.0001 
0.00971 
0.4483 
0.12738 
<.0001 
-0.01078 
0.3996 
-0.01078 
0.3996 
-0.01078 
0.3996 
FL7 
ANTHO-Peonidin 
0.10896 
<.0001 
0.01134 
0.3758 
0.10429 
<.0001 
0.12486 
<.0001 
0.60330 
<.0001 
0.28493 
<.0001 
-0.02227 
0.0819 
-0.02227 
0.0819 
-0.02227 
0.0819 
FL8 
ANTHO-Petunidin 
0.10144 
<.0001 
0.00058 
0.9641 
0.09377 
<.0001 
0.11305 
<.0001 
0.60236 
<.0001 
0.26832 
<.0001 
-0.02111 
0.0990 
-0.02111 
0.0990 
-0.02111 
0.0990 
FL9 
FLAVAN3-(+)-Catechin 
0.18733 
<.0001 
0.07687 
<.0001 
0.12383 
<.0001 
0.21774 
<.0001 
0.63963 
<.0001 
0.37464 
<.0001 
0.09506 
<.0001 
0.09506 
<.0001 
0.09506 
<.0001 
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FL29 
Proanthocyanidin-Monomers 
0.26703 
<.0001 
0.14540 
<.0001 
0.13724 
<.0001 
0.29925 
<.0001 
0.63041 
<.0001 
0.43056 
<.0001 
0.20713 
<.0001 
0.20713 
<.0001 
0.20713 
<.0001 
FL30 
Proanthocyanidin-Dimers 
0.20539 
<.0001 
0.10627 
<.0001 
0.14489 
<.0001 
0.22359 
<.0001 
0.60279 
<.0001 
0.45958 
<.0001 
0.07197 
<.0001 
0.07197 
<.0001 
0.07197 
<.0001 
FL31 
Proanthocyanidin-Trimers 
0.25836 
<.0001 
0.20895 
<.0001 
0.17308 
<.0001 
0.22776 
<.0001 
0.24898 
<.0001 
0.55183 
<.0001 
0.07362 
<.0001 
0.07362 
<.0001 
0.07362 
<.0001 
FL32 
Proanthocyanidin-4-6mers 
0.28276 
<.0001 
0.21537 
<.0001 
0.19611 
<.0001 
0.23158 
<.0001 
0.28007 
<.0001 
0.58719 
<.0001 
0.04756 
0.0002 
0.04756 
0.0002 
0.04756 
0.0002 
FL33 
Proanthocyanidin-7-10mers 
0.29838 
<.0001 
0.22224 
<.0001 
0.20154 
<.0001 
0.23476 
<.0001 
0.26600 
<.0001 
0.60404 
<.0001 
0.04835 
0.0002 
0.04835 
0.0002 
0.04835 
0.0002 
FL34 
Proanthocyanidin-Polymers 
0.36692 
<.0001 
0.23924 
<.0001 
0.22904 
<.0001 
0.24036 
<.0001 
0.28961 
<.0001 
0.56550 
<.0001 
0.04108 
0.0013 
0.04108 
0.0013 
0.04108 
0.0013 
 
 
 FL28 FL29 FL30 FL31 FL32 FL33 FL34 
FL1 
ISO-DAIDZEINA 
-0.00846 
0.5084 
-0.00530 
0.6785 
0.00155 
0.9035 
0.04046 
0.0016 
0.04170 
0.0011 
0.04539 
0.0004 
0.03587 
0.0051 
FL2 
ISO-GENISTEIN 
-0.00859 
0.5023 
-0.01185 
0.3546 
-0.01073 
0.4019 
0.00516 
0.6871 
0.00594 
0.6428 
0.00701 
0.5838 
0.01013 
0.4286 
FL3 
ANTHO-Cyanidin 
-0.00548 
0.6686 
0.12265 
<.0001 
0.13388 
<.0001 
0.23331 
<.0001 
0.26208 
<.0001 
0.25419 
<.0001 
0.33152 
<.0001 
FL4 
ANTHO-Delphinidin 
-0.02112 
0.0988 
0.90762 
<.0001 
0.90819 
<.0001 
0.26243 
<.0001 
0.31610 
<.0001 
0.29333 
<.0001 
0.32649 
<.0001 
FL5 
ANTHO-Malvidin 
-0.02110 
0.0992 
0.90763 
<.0001 
0.90819 
<.0001 
0.26244 
<.0001 
0.31612 
<.0001 
0.29334 
<.0001 
0.32651 
<.0001 
FL6 
ANTHO-Pelargonidin 
-0.01078 
0.3996 
0.01652 
0.1968 
0.02627 
0.0401 
0.17204 
<.0001 
0.18929 
<.0001 
0.17983 
<.0001 
0.24344 
<.0001 
FL7 
ANTHO-Peonidin 
-0.02227 
0.0819 
0.90909 
<.0001 
0.91092 
<.0001 
0.28491 
<.0001 
0.34091 
<.0001 
0.31698 
<.0001 
0.35854 
<.0001 
FL8 
ANTHO-Petunidin 
-0.02111 
0.0990 
0.90762 
<.0001 
0.90818 
<.0001 
0.26241 
<.0001 
0.31609 
<.0001 
0.29332 
<.0001 
0.32648 
<.0001 
FL9 
FLAVAN3-(+)-Catechin 
0.09506 
<.0001 
0.94713 
<.0001 
0.94521 
<.0001 
0.37760 
<.0001 
0.43394 
<.0001 
0.41364 
<.0001 
0.45822 
<.0001 
FL10 
FLAVAN3-(-)-Epigallocatechin 
1.00000 
<.0001 
0.20714 
<.0001 
0.07198 
<.0001 
0.07363 
<.0001 
0.04757 
0.0002 
0.04836 
0.0002 
0.04109 
0.0013 
FL11 
FLAVAN3-(-)-Epicatechin 
0.22076 
<.0001 
0.82386 
<.0001 
0.86773 
<.0001 
0.75550 
<.0001 
0.80366 
<.0001 
0.81520 
<.0001 
0.73313 
<.0001 
FL12 
FLAVAN3-(-)-Epicatechin 3-gallate 
0.99212 
<.0001 
0.21362 
<.0001 
0.08209 
<.0001 
0.09984 
<.0001 
0.07771 
<.0001 
0.08022 
<.0001 
0.09713 
<.0001 
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FL13 
FLAVAN3-(-)-Epigallocatechin 3-gallate 
1.00000 
<.0001 
0.20713 
<.0001 
0.07197 
<.0001 
0.07362 
<.0001 
0.04756 
0.0002 
0.04835 
0.0002 
0.04108 
0.0013 
FL14 
FLAVAN3-Theaflavin 
1.00000 
<.0001 
0.20713 
<.0001 
0.07197 
<.0001 
0.07362 
<.0001 
0.04756 
0.0002 
0.04835 
0.0002 
0.04108 
0.0013 
FL15 
FLAVAN3-Thearubigins 
1.00000 
<.0001 
0.20713 
<.0001 
0.07197 
<.0001 
0.07362 
<.0001 
0.04756 
0.0002 
0.04835 
0.0002 
0.04108 
0.0013 
FL16 
FLAVA-Eriodictyol 
0.09964 
<.0001 
0.02357 
0.0655 
0.01686 
0.1876 
0.12882 
<.0001 
0.12387 
<.0001 
0.11527 
<.0001 
0.13077 
<.0001 
FL17 
FLAVA-Hesperetin 
0.01519 
0.2354 
0.02909 
0.0230 
0.05317 
<.0001 
0.21864 
<.0001 
0.22661 
<.0001 
0.21463 
<.0001 
0.24003 
<.0001 
FL18 
FLAVA-naringenin 
0.01934 
0.1307 
0.00788 
0.5379 
0.02833 
0.0268 
0.19303 
<.0001 
0.19938 
<.0001 
0.18937 
<.0001 
0.21176 
<.0001 
FL19 
FLAVONE-Apigenin 
0.52753 
<.0001 
0.26703 
<.0001 
0.20539 
<.0001 
0.25836 
<.0001 
0.28276 
<.0001 
0.29838 
<.0001 
0.36692 
<.0001 
FL20 
FLAVONE-Luteolin 
0.39969 
<.0001 
0.14540 
<.0001 
0.10627 
<.0001 
0.20895 
<.0001 
0.21537 
<.0001 
0.22224 
<.0001 
0.23924 
<.0001 
FL21 
FLAVONO-Isorhamnetin 
0.03827 
0.0028 
0.13724 
<.0001 
0.14489 
<.0001 
0.17308 
<.0001 
0.19611 
<.0001 
0.20154 
<.0001 
0.22904 
<.0001 
FL22 
FLAVONO-Kaempferol 
0.67439 
<.0001 
0.29925 
<.0001 
0.22359 
<.0001 
0.22776 
<.0001 
0.23158 
<.0001 
0.23476 
<.0001 
0.24036 
<.0001 
FL23 
FLAVONO-Myricetin 
0.25782 
<.0001 
0.63041 
<.0001 
0.60279 
<.0001 
0.24898 
<.0001 
0.28007 
<.0001 
0.26600 
<.0001 
0.28961 
<.0001 
FL24 
FLAVONO-Quercetin 
0.22408 
<.0001 
0.43056 
<.0001 
0.45958 
<.0001 
0.55183 
<.0001 
0.58719 
<.0001 
0.60404 
<.0001 
0.56550 
<.0001 
FL25 
FLAVAN3-Theaflavin-3,3'-digallate 
1.00000 
<.0001 
0.20713 
<.0001 
0.07197 
<.0001 
0.07362 
<.0001 
0.04756 
0.0002 
0.04835 
0.0002 
0.04108 
0.0013 
FL26 
FLAVAN3-Theaflavin-3'-gallate 
1.00000 
<.0001 
0.20713 
<.0001 
0.07197 
<.0001 
0.07362 
<.0001 
0.04756 
0.0002 
0.04835 
0.0002 
0.04108 
0.0013 
FL27 
FLAVAN3-Theaflavin-3-gallate 
1.00000 
<.0001 
0.20713 
<.0001 
0.07197 
<.0001 
0.07362 
<.0001 
0.04756 
0.0002 
0.04835 
0.0002 
0.04108 
0.0013 
FL28 
FLAVAN3-(+)-Gallocatechin 
1.00000 
 
0.20713 
<.0001 
0.07197 
<.0001 
0.07362 
<.0001 
0.04756 
0.0002 
0.04835 
0.0002 
0.04108 
0.0013 
FL29 
Proanthocyanidin-Monomers 
0.20713 
<.0001 
1.00000 
 
0.98396 
<.0001 
0.58204 
<.0001 
0.60685 
<.0001 
0.57199 
<.0001 
0.59854 
<.0001 
FL30 
Proanthocyanidin-Dimers 
0.07197 
<.0001 
0.98396 
<.0001 
1.00000 
 
0.63606 
<.0001 
0.67168 
<.0001 
0.64423 
<.0001 
0.64972 
<.0001 
FL31 
Proanthocyanidin-Trimers 
0.07362 
<.0001 
0.58204 
<.0001 
0.63606 
<.0001 
1.00000 
 
0.99023 
<.0001 
0.97349 
<.0001 
0.93216 
<.0001 
FL32 
Proanthocyanidin-4-6mers 
0.04756 
0.0002 
0.60685 
<.0001 
0.67168 
<.0001 
0.99023 
<.0001 
1.00000 
 
0.99329 
<.0001 
0.95214 
<.0001 
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FL33 
Proanthocyanidin-7-10mers 
0.04835 
0.0002 
0.57199 
<.0001 
0.64423 
<.0001 
0.97349 
<.0001 
0.99329 
<.0001 
1.00000 
 
0.94771 
<.0001 
FL34 
Proanthocyanidin-Polymers 
0.04108 
0.0013 
0.59854 
<.0001 
0.64972 
<.0001 
0.93216 
<.0001 
0.95214 
<.0001 
0.94771 
<.0001 
1.00000 
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Figure 1 (Appendix 3) -  Multiple logistic regression-derived odds ratios (ORs)
 
 and corresponding 
95% confidence intervals (CI) for in 1953 cases of colorectal cancer and 4154 controls, according to 
the highest versus the lowest quintiles of selected classes of flavonoids (with significant inverse 
association). Italy, 1992-1996. 
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Figure 2 (Appendix 3) - Percentages of intake deriving from different sources for each flavonoids among 
all subjects of colorectal cancer studies. Italy, 1992-1996 
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Figure 3 (Appendix 3) - Percentages of intake deriving from different sources for each flavonoids by 
group inserted in FA among all subjects of colorectal cancer studies. Italy, 1992-1996 . 
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Figure 4 (Appendix 3) - Percentages of intake deriving from different sources for each flavonoids by 
group inserted in FA and corresponding factor (from FA with 4 factors) among all subjects of 
colorectal cancer studies. Italy, 1992-1996  
Figure 4 – a) factor 1 
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Figure 4 – b) factor 2 
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Figure 4 – c) factor 3 
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Figure 4 – d) factor 4 
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Figure 5 (Appendix 3) - Multiple logistic regression-derived odds ratios (ORs)
a 
 and 
corresponding 95% confidence intervals (CI) for colorectal cancer, according to the 
second and third tertiles (factorit2 and factorit3 for i=1,…,5) versus the lowest tertile of 
factors. Italy, 1992-1996. 
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17 
Figure 6 (Appendix 3) - Mean Intake of proanthocyanidins, monomers and dimers combined 
and polymers with three or more mers, deriving by wine and by other sources among of 805 oral 
cavity and pharyngeal cancer cases and 2,081. Italy, 1992-2005 
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Figure 7 (Appendix 3) - Multiple logistic regression-derived odds ratios (ORs)
 
 and corresponding 
95% confidence intervals (CI) for oral cavity and pharyngeal cancer, according to the highest versus 
the lowest tertile of monomer and dimer proanthocyanidins combined and proanthocyanidins with 
three or more mers, deriving by wine and without intake from wine. Italy, 1992-2005.
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Figure 8 (Appendix 3) - Multiple logistic regression-derived odds ratios (ORs)
 
 and 
corresponding 95% confidence intervals (CI) for oral cavity and pharyngeal cancer, according to 
the second and third tertiles (factorit2 and factorit3 for i=1,2,3) versus the lowest tertile of factors. 
Italy, 1992-2005. 
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Figure 9 (Appendix 3) a), b) - Distribution of 2886 subjects from oral and pharyngeal cancer study according to levels of factor 1 and factor 3 and 
levels of alcohol habits and factor 3. Italy, 1992-2005. 
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Figure 10 (Appendix 3) a), b) - Multiple logistic regression-derived odds ratios (ORs) for oral cavity and pharyngeal cancer, according to highest 
versus the lowest level of factor 1 and factor 3, and of alcohol habits and factor 3 . Italy, 1992-2005. 
a)                                                                                                                     b) 
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Figure 11 (Appendix 3) - Multiple logistic regression-derived odds ratios (ORs)
 
 and corresponding 
95% confidence intervals (CI) for oral cavity and pharyngeal cancer, according to the highest versus 
the lowest quintile of flavonoid intake and residuals of flavonoids on FRAP. Italy, 1992-2005. 
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APPENDIX 4 – Chapter 7 
 
Figure 1 (Appendix 4) - Multiple logistic regression-derived odds ratios (ORs)
 
 and corresponding 95% 
confidence intervals (CI) for oral cavity and pharyngeal cancer, according to the highest versus the lowest 
quintile of flavonoid intake and residuals of flavonoids on fruit and vegetables and on water. Italy, 1992-2005.
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APPENDIX 4 – SAS programs 
 
data a; 
set die.colon; 
run; 
proc sort data=a; 
by v2; 
run; 
ods rtf file='C:\Users\mrossi\Desktop\TESI\OUTPUT\means1.doc'; 
proc means data=a MAXDEC=2; 
var fl1-fl34; 
by v2; 
run; 
ods rtf close; 
 
proc univariate PLOT; 
var fl1-fl34; 
run; 
proc univariate normaltest;; 
var fl1-fl34; 
where v2=2; 
run; 
proc univariate normaltest; PROBPLOT fl1/normal (mu=est sigma=est) ; 
var fl1-fl34; 
run; 
proc univariate data=a normaltest; QQPLOT fl1/normal (mu=est sigma=est) ; 
var fl1-fl34;histogram fl1-fl34; 
run; 
 
ods rtf file='C:\Users\mrossi\Desktop\TESI\OUTPUT\corr1.doc'; 
proc corr data=a ; 
var fl1-fl34; 
run; 
ods rtf close; 
 
 
proc standard data=a mean=0 std=1 out=stand;   
var fl1-fl34 ali1-ali78 pro prop prott; 
run; 
 
data b (keep=v1 v2 v4 fl1-fl34 ali1-ali78 pro prop prott); 
set stand; 
run; 
 
 
ods rtf file='C:\Users\mrossi\Desktop\TESI\OUTPUT\factor1.doc'; 
title1 'Analisi fattoriale, rotazione=varimax, metodo=principal (...)'; 
proc factor data=b method=principal corr score res /*out=primaf*/ msa 
mineigen=1 priors=one /*n=1*/ r=varimax scree ; 
var fl1-fl34; 
run; 
ods rtf close; 
 
 
proc factor data=b method=principal corr score res /*out=primaf*/ msa 
mineigen=1   priors=one n=3 r=varimax scree; 
var fl3 fl9 fl10 fl16 fl17 fl19 fl20-fl24 fl29 fl31; 
run;/* MSA TOT = 0.55*/ 
 
proc factor data=b method=principal corr score res /*out=primaf*/ msa 
mineigen=1   priors=one n=3 r=varimax scree; 
var fl3 fl4 fl10 fl11 fl16 fl17 fl19-fl24 fl29 fl31; 
run;/* MSA TOT= 0.47 */ 
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proc factor data=b method=principal corr score res /*out=primaf*/ msa 
mineigen=1   priors=one n=3 r=varimax scree; 
var fl3 fl4 fl10 fl11 fl16 fl17 fl19-fl24 fl29 ; 
run;/* MSA TOT= 0.68 */ 
 
proc factor data=b method=principal corr score res /*out=primaf*/ msa 
mineigen=1   priors=one n=3 r=varimax scree; 
var fl3 fl4 fl10 fl11 fl16 fl17 fl19-fl24 fl31 ; 
run;/* MSA TOT= 0.60 */ 
 
proc factor data=b method=principal corr score res /*out=primaf*/ msa 
mineigen=1   priors=one n=3 r=varimax scree; 
var fl1 fl3 fl4 fl10 fl11 fl16 fl17 fl19-fl24 fl29 fl31; 
run;/* MSA TOT= 0.47 */  
 
 
data aa; 
set a; 
s3=fl3+fl6; 
s4=fl4+fl5+fl7+fl8+fl9; 
s10=fl10+fl12+fl13+fl14+fl15+fl25+fl26+fl27+fl28; 
s11=fl11; 
s16=fl6; 
s17=fl7+fl18; 
s19=fl9; 
s20=fl20; 
s21=fl21; 
s22=fl22; 
s23=fl23; 
s24=fl24; 
s29=fl29+fl30; 
s31=fl31+fl32+fl33+fl34; 
run; 
 
proc standard data=aa mean=0 std=1 out=stand;   
var fl1-fl34 ali1-ali78 pro prop prott s3 s4 s10 s11 s16 s17 s19-s24 s29 
s31; 
run; 
 
data b (keep=v1 v2 v4 fl1-fl34 ali1-ali78 pro prop prott s3 s4 s10 s11 s16 
s17 s19-s24 s29 s31); 
set stand; 
run; 
 
ods rtf file='C:\Users\mrossi\Desktop\TESI\OUTPUT\factor1.doc'; 
proc factor data=b method=principal corr score res out=primaf msa 
/*mineigen=1*/ /*heywood*/   priors=one n=5 r=varimax scree; 
var s3 s4 s10 s11 s16 s17 s19-s24 s29 s31; 
run; 
 
proc princomp data=b score n=5 ; 
var s3 s4 s10 s11 s16 s17 s19-s24 s29 s31; 
run; 
ods rtf close;/* MSA TOT= 0.61 */ 
 
 
* 4 factors ; 
proc sort data=aa; 
by  v1 v2 v4; 
run; 
proc sort data=primaf; 
by  v1 v2 v4; 
run; 
data merge4; 
merge aa primaf; 
3 
by v1 v2 v4; 
run; 
 
data aaa; 
set merge4; 
where v2=2; 
run; 
 
*****TERTILES****************; 
%macro terz; 
%let c1=factor1; 
%let c2=factor2; 
%let c3=factor3; 
%let c4=factor4; 
%do i=1 %to 4; 
proc univariate data=aaa noprint; 
var &&c&i; 
output out=pp pctlpts=33.3 66.6  
       pctlpre=pr&&c&i ; 
run ; 
  
proc print data=pp; 
run; 
 
%macro perc(nom) ; 
    data _null_; 
         set pp ; 
         %global &nom.33_3 &nom.66_6 ; 
         call symput("&nom.33_3",&nom.33_3); 
         call symput("&nom.66_6",&nom.66_6); 
    run; 
   data _null_ ; 
    %put &&&nom.33_3 ; 
    %put &&&nom.66_6 ; 
   
%mend ; 
 
 
%perc(pr&&c&i) ; 
 
%let a=pr&&c&i..33_3; 
%let b=pr&&c&i..66_6; 
 
data merge4; 
   set merge4; 
%dumm(&&c&i,&&c&i..t,2,&&&a,&&&b) ; 
&&c&i..tfr=&&c&i..t1+2*&&c&i..t2+3*&&c&i..t3; 
run; 
%end; 
%mend; 
%terz; 
 
proc logistic data=merge4; 
model v2=factor1t2-factor1t3 factor2t2-factor2t3 factor3t2-factor3t3 
factor4t2-factor4t3 etaq1-etaq3 etaq5-etaq7 sex2 cen2-cen6    edu2 edu3 
nnfis2 nnfis3  
famint bmi2-bmi5 alcol2-alcol4 ennoal2-ennoal5; 
run; 
 
* 5 factors; 
proc factor data=b method=principal corr score res out=primaf msa 
/*mineigen=1*/ /*heywood*/   priors=one n=5 r=varimax scree; 
var s3 s4 s10 s11 s16 s17 s19-s24 s29 s31; 
run; 
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proc sort data=aa; 
by  v1 v2 v4; 
run; 
proc sort data=primaf; 
by  v1 v2 v4; 
run; 
data merge5; 
merge aa primaf; 
by v1 v2 v4; 
run; 
data aaa; 
set merge5; 
where v2=2; 
run; 
%macro terz; 
%let c1=factor1; 
%let c2=factor2; 
%let c3=factor3; 
%let c4=factor4; 
%let c5=factor5; 
 
%do i=1 %to 5; 
proc univariate data=aaa noprint; 
var &&c&i; 
output out=pp pctlpts=33.3 66.6  
       pctlpre=pr&&c&i ; 
run ; 
  
proc print data=pp; 
run; 
 
%macro perc(nom) ; 
    data _null_; 
         set pp ; 
         %global &nom.33_3 &nom.66_6 ; 
         call symput("&nom.33_3",&nom.33_3); 
         call symput("&nom.66_6",&nom.66_6); 
    run; 
   data _null_ ; 
    %put &&&nom.33_3 ; 
    %put &&&nom.66_6 ; 
   
%mend ; 
 
 
%perc(pr&&c&i) ; 
 
%let a=pr&&c&i..33_3; 
%let b=pr&&c&i..66_6; 
 
data merge5; 
   set merge5; 
%dumm(&&c&i,&&c&i..t,2,&&&a,&&&b) ; 
&&c&i..tfr=&&c&i..t1+2*&&c&i..t2+3*&&c&i..t3; 
run; 
%end; 
%mend; 
%terz; 
 
proc logistic data=merge5; 
model v2=factor1t2-factor1t3 factor2t2-factor2t3 factor3t2-factor3t3 
factor4t2-factor4t3 factor5t2-factor5t3  etaq1-etaq3 etaq5-etaq7 sex2 cen2-
cen6    edu2 edu3 nnfis2 nnfis3  
famint bmi2-bmi5 alcol2-alcol4 ennoal2-ennoal5; 
ods output oddsratios = ff; 
5 
run; 
proc logistic data=merge5; 
model v2=factor1tfr factor2tfr factor3tfr factor4tfr factor5tfr  etaq1-
etaq3 etaq5-etaq7 sex2 cen2-cen6    edu2 edu3 nnfis2 nnfis3  
famint bmi2-bmi5 alcol2-alcol4 ennoal2-ennoal5; 
ods output oddsratios = ff; 
run; 
proc univariate data=merge5 normaltest; PROBPLOT factor1/normal (mu=est 
sigma=est) ; 
var factor1;histogram factor1; 
run; 
proc univariate data=merge5 normaltest; PROBPLOT factor2/normal (mu=est 
sigma=est) ; 
var factor2;histogram factor2; 
run; 
proc univariate data=merge5 normaltest; PROBPLOT factor3/normal (mu=est 
sigma=est) ; 
var factor3;histogram factor3; 
run; 
proc univariate data=merge5 normaltest; PROBPLOT factor4/normal (mu=est 
sigma=est) ; 
var factor4;histogram factor4; 
run; 
proc univariate data=merge5 normaltest; PROBPLOT factor5/normal (mu=est 
sigma=est) ; 
var factor5;histogram factor5; 
run; 
 
 
*****QUINTILES****************; 
%macro q1; 
 
%let c1=factor1; 
%let c2=factor2; 
%let c3=factor3; 
%let c4=factor4; 
%let c5=factor5; 
 
%do i=1 %to 5; 
proc univariate data=aaa NOPRINT ; 
     var &&c&i ; 
    output out=pp pctlpts=20 40 60 80  
       pctlpre=pr&&c&i ; 
run ; 
proc print data=pp; 
run; 
%macro perc(nom) ; 
    data _null_; 
         set pp ; 
         %global &nom.20 &nom.40 &nom.60 &nom.80 ; 
         call symput("&nom.20",&nom.20); 
         call symput("&nom.40",&nom.40); 
         call symput("&nom.60",&nom.60); 
          call symput("&nom.80",&nom.80); 
    run; 
   data _null_ ; 
    %put &&&nom.20 ; 
    %put &&&nom.40 ; 
    %put &&&nom.60 ; 
    %put &&&nom.80 ; 
%mend ; 
 
%perc(pr&&c&i) ; 
 
%let a=pr&&c&i..20; 
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%let b=pr&&c&i..40; 
%let c=pr&&c&i..60; 
%let d=pr&&c&i..80; 
 
 
data merge5; 
   set merge5; 
%dumm(&&c&i,&&c&i,4,&&&a,&&&b, &&&c,&&&d) ; 
&&c&i..fr=&&c&i..1+2*&&c&i..2+3*&&c&i..3+ 
                4*&&c&i..4+5*&&c&i..5 ; 
&&c&i..cq=&&c&i/(&&&d-&&&a); 
 
run; 
%end; 
%mend; 
%q1; 
 
proc logistic data=merge5; 
model v2=factor12-factor15 factor22-factor25 factor32-factor35 factor42-
factor45 factor52-factor55  etaq1-etaq3 etaq5-etaq7 sex2 cen2-cen6    edu2 
edu3 nnfis2 nnfis3  
famint bmi2-bmi5 alcol2-alcol4 ennoal2-ennoal5; 
run; 
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